Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tfdp1
|
ENSMUSG00000038482.10 | transcription factor Dp 1 |
Wt1
|
ENSMUSG00000016458.7 | Wilms tumor 1 homolog |
Egr2
|
ENSMUSG00000037868.9 | early growth response 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_67537527_67537731 | Egr2 | 240 | 0.893902 | 0.51 | 3.3e-05 | Click! |
chr10_67538270_67539277 | Egr2 | 90 | 0.955897 | 0.42 | 8.7e-04 | Click! |
chr10_67537793_67538017 | Egr2 | 25 | 0.966414 | 0.36 | 5.2e-03 | Click! |
chr10_67535333_67535484 | Egr2 | 67 | 0.961548 | 0.20 | 1.2e-01 | Click! |
chr10_67535522_67536456 | Egr2 | 406 | 0.788120 | 0.20 | 1.2e-01 | Click! |
chr8_13352592_13353219 | Tfdp1 | 12265 | 0.115944 | -0.49 | 6.5e-05 | Click! |
chr8_13353328_13353619 | Tfdp1 | 11697 | 0.116815 | -0.48 | 1.0e-04 | Click! |
chr8_13340762_13341183 | Tfdp1 | 1298 | 0.322455 | -0.42 | 8.0e-04 | Click! |
chr8_13351770_13352009 | Tfdp1 | 12215 | 0.115912 | -0.34 | 8.9e-03 | Click! |
chr8_13354305_13354456 | Tfdp1 | 10790 | 0.118256 | -0.32 | 1.2e-02 | Click! |
chr2_105129293_105129444 | Wt1 | 1432 | 0.371816 | -0.27 | 3.4e-02 | Click! |
chr2_105135104_105135514 | Wt1 | 4426 | 0.205348 | -0.23 | 7.5e-02 | Click! |
chr2_105130039_105131439 | Wt1 | 61 | 0.971644 | -0.19 | 1.4e-01 | Click! |
chr2_105141772_105141928 | Wt1 | 10967 | 0.179256 | -0.18 | 1.6e-01 | Click! |
chr2_105141577_105141728 | Wt1 | 10769 | 0.179533 | -0.16 | 2.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_170674573_170675954 | 25.01 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr15_74563319_74564610 | 18.18 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
63 |
0.61 |
chr7_44310203_44311401 | 18.03 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
549 |
0.46 |
chr2_164967685_164969910 | 15.63 |
Slc12a5 |
solute carrier family 12, member 5 |
516 |
0.7 |
chr19_6418703_6419936 | 15.04 |
Nrxn2 |
neurexin II |
554 |
0.44 |
chr4_127988222_127989180 | 14.22 |
Csmd2 |
CUB and Sushi multiple domains 2 |
657 |
0.77 |
chr15_74516560_74519631 | 14.07 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
1264 |
0.47 |
chr7_4690708_4691898 | 14.05 |
Brsk1 |
BR serine/threonine kinase 1 |
223 |
0.84 |
chr7_44441951_44442938 | 14.04 |
Lrrc4b |
leucine rich repeat containing 4B |
41 |
0.93 |
chr7_79498955_79500626 | 13.84 |
Mir9-3hg |
Mir9-3 host gene |
236 |
0.84 |
chr6_114282516_114283979 | 13.58 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr10_127533543_127535232 | 13.37 |
Nxph4 |
neurexophilin 4 |
172 |
0.9 |
chr7_44336079_44337576 | 13.03 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
811 |
0.34 |
chr14_5070665_5071726 | 12.85 |
Gm8281 |
predicted gene, 8281 |
155 |
0.94 |
chr2_152081612_152083149 | 12.77 |
Scrt2 |
scratch family zinc finger 2 |
851 |
0.52 |
chr5_120710211_120711265 | 12.63 |
Dtx1 |
deltex 1, E3 ubiquitin ligase |
1189 |
0.31 |
chr14_4018473_4019517 | 12.45 |
Gm5796 |
predicted gene 5796 |
4946 |
0.14 |
chr8_95677661_95678715 | 12.29 |
Ndrg4 |
N-myc downstream regulated gene 4 |
57 |
0.95 |
chr8_121730928_121732115 | 12.26 |
Jph3 |
junctophilin 3 |
954 |
0.49 |
chr2_25877424_25878675 | 12.20 |
Kcnt1 |
potassium channel, subfamily T, member 1 |
168 |
0.93 |
chr9_20745303_20746611 | 12.14 |
Olfm2 |
olfactomedin 2 |
392 |
0.82 |
chr1_93100315_93101980 | 12.07 |
Kif1a |
kinesin family member 1A |
675 |
0.62 |
chr9_22050521_22051976 | 11.80 |
Elavl3 |
ELAV like RNA binding protein 3 |
762 |
0.41 |
chr2_158610228_158611991 | 11.70 |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
342 |
0.44 |
chr15_75565940_75567228 | 11.56 |
Ly6h |
lymphocyte antigen 6 complex, locus H |
48 |
0.96 |
chr3_89243498_89245184 | 11.53 |
Trim46 |
tripartite motif-containing 46 |
672 |
0.36 |
chr7_134937525_134938356 | 11.40 |
Insyn2a |
inhibitory synaptic factor 2A |
338 |
0.9 |
chr7_43489310_43490670 | 11.39 |
Iglon5 |
IgLON family member 5 |
85 |
0.92 |
chr12_75176309_75177605 | 11.35 |
Kcnh5 |
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
375 |
0.92 |
chr5_108549212_108550612 | 11.32 |
Cplx1 |
complexin 1 |
88 |
0.95 |
chr4_124861345_124862773 | 11.26 |
Maneal |
mannosidase, endo-alpha-like |
112 |
0.93 |
chr15_76519928_76521866 | 11.25 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr15_89059381_89060565 | 11.24 |
Panx2 |
pannexin 2 |
226 |
0.86 |
chr11_94472657_94474433 | 11.23 |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
96 |
0.95 |
chr7_25071787_25073006 | 11.20 |
Grik5 |
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
50 |
0.66 |
chr7_44428985_44430475 | 11.10 |
Lrrc4b |
leucine rich repeat containing 4B |
712 |
0.43 |
chr7_141949754_141950818 | 10.98 |
Brsk2 |
BR serine/threonine kinase 2 |
200 |
0.83 |
chr11_120720985_120722324 | 10.83 |
Rac3 |
Rac family small GTPase 3 |
81 |
0.9 |
chr10_81481482_81482676 | 10.74 |
Celf5 |
CUGBP, Elav-like family member 5 |
593 |
0.47 |
chr7_126823319_126824529 | 10.72 |
Fam57b |
family with sequence similarity 57, member B |
621 |
0.41 |
chr6_118011118_118012108 | 10.67 |
Rasgef1a |
RasGEF domain family, member 1A |
175 |
0.94 |
chr14_6889307_6890296 | 10.67 |
Gm3667 |
predicted gene 3667 |
161 |
0.95 |
chr7_27333625_27333898 | 10.65 |
Ltbp4 |
latent transforming growth factor beta binding protein 4 |
98 |
0.94 |
chr1_92849002_92850443 | 10.54 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr2_178141581_178143125 | 10.50 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr10_60106298_60107716 | 10.50 |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
539 |
0.78 |
chr1_75382045_75382883 | 10.45 |
Speg |
SPEG complex locus |
326 |
0.79 |
chr14_4855192_4856263 | 10.37 |
Gm3264 |
predicted gene 3264 |
151 |
0.94 |
chr15_34837199_34838365 | 10.35 |
Kcns2 |
K+ voltage-gated channel, subfamily S, 2 |
267 |
0.93 |
chr7_4119233_4120703 | 10.34 |
Ttyh1 |
tweety family member 1 |
214 |
0.7 |
chr14_6037555_6038593 | 10.32 |
Gm8206 |
predicted gene 8206 |
135 |
0.93 |
chr19_6497246_6498663 | 10.31 |
Nrxn2 |
neurexin II |
119 |
0.94 |
chr11_69836688_69838020 | 10.30 |
Nlgn2 |
neuroligin 2 |
430 |
0.51 |
chr19_46317017_46318641 | 10.30 |
Psd |
pleckstrin and Sec7 domain containing |
238 |
0.83 |
chr7_25004827_25006284 | 10.29 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
340 |
0.79 |
chr14_3571642_3572719 | 10.27 |
Gm3005 |
predicted gene 3005 |
157 |
0.94 |
chr10_110455062_110456014 | 10.26 |
Nav3 |
neuron navigator 3 |
666 |
0.75 |
chr1_135374257_135375340 | 10.19 |
Shisa4 |
shisa family member 4 |
279 |
0.86 |
chr2_70561988_70564432 | 10.18 |
Gad1os |
glutamate decarboxylase 1, opposite strand |
147 |
0.61 |
chr14_4110158_4111243 | 10.08 |
Gm8108 |
predicted gene 8108 |
174 |
0.93 |
chr14_3412245_3413254 | 10.06 |
Gm10409 |
predicted gene 10409 |
135 |
0.93 |
chr8_32883592_32884962 | 10.04 |
Nrg1 |
neuregulin 1 |
23 |
0.99 |
chr12_24680420_24681760 | 10.01 |
Cys1 |
cystin 1 |
67 |
0.96 |
chr14_4415079_4416266 | 10.00 |
Gm3164 |
predicted gene 3164 |
224 |
0.89 |
chr14_3809696_3810741 | 9.94 |
Gm3002 |
predicted gene 3002 |
144 |
0.94 |
chr4_22487396_22488284 | 9.87 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
526 |
0.73 |
chr5_130448513_130449808 | 9.87 |
Caln1 |
calneuron 1 |
359 |
0.91 |
chr17_6489757_6490685 | 9.86 |
Tmem181b-ps |
transmembrane protein 181B, pseudogene |
23199 |
0.14 |
chrX_150656320_150657724 | 9.86 |
Tro |
trophinin |
350 |
0.85 |
chr6_114041186_114042349 | 9.78 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
248 |
0.91 |
chr14_6286765_6287923 | 9.77 |
Gm3411 |
predicted gene 3411 |
94 |
0.95 |
chr11_98327227_98329144 | 9.73 |
Neurod2 |
neurogenic differentiation 2 |
1463 |
0.23 |
chr8_17534365_17535810 | 9.67 |
Csmd1 |
CUB and Sushi multiple domains 1 |
194 |
0.97 |
chr13_69534264_69534660 | 9.62 |
Tent4a |
terminal nucleotidyltransferase 4A |
155 |
0.86 |
chr8_94869714_94871671 | 9.62 |
Dok4 |
docking protein 4 |
512 |
0.65 |
chr14_7244023_7245062 | 9.58 |
Gm5456 |
predicted gene 5456 |
3100 |
0.18 |
chr19_5297797_5299076 | 9.58 |
Gal3st3 |
galactose-3-O-sulfotransferase 3 |
105 |
0.9 |
chr1_162476870_162477973 | 9.56 |
Gm10176 |
predicted gene 10176 |
259 |
0.76 |
chr6_42323611_42324574 | 9.56 |
Fam131b |
family with sequence similarity 131, member B |
500 |
0.63 |
chr4_120282318_120283616 | 9.53 |
Foxo6 |
forkhead box O6 |
4382 |
0.24 |
chr12_87026152_87027307 | 9.50 |
Tmem63c |
transmembrane protein 63c |
113 |
0.95 |
chr7_19082814_19086200 | 9.49 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr17_6256598_6257723 | 9.48 |
Tmem181a |
transmembrane protein 181A |
210 |
0.91 |
chr9_86879335_86880899 | 9.43 |
Snap91 |
synaptosomal-associated protein 91 |
280 |
0.93 |
chr15_78119178_78120215 | 9.42 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
10 |
0.83 |
chr14_66344363_66345813 | 9.36 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr2_54436341_54437219 | 9.36 |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
289 |
0.94 |
chr14_19584548_19585598 | 9.27 |
Gm2237 |
predicted gene 2237 |
62 |
0.95 |
chr9_26733362_26733763 | 9.24 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
166 |
0.94 |
chr3_8509825_8511666 | 9.18 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr17_6320795_6321910 | 9.18 |
AC183097.1 |
transmembrane protein 181 (TMEM181) pseudogene |
384 |
0.76 |
chrX_73503094_73503593 | 9.17 |
Atp2b3 |
ATPase, Ca++ transporting, plasma membrane 3 |
257 |
0.88 |
chr14_55114527_55116659 | 9.16 |
Jph4 |
junctophilin 4 |
41 |
0.94 |
chr5_134746440_134747928 | 9.15 |
Eln |
elastin |
62 |
0.61 |
chr7_44335441_44336039 | 9.15 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
276 |
0.76 |
chr5_63968955_63969288 | 9.09 |
Rell1 |
RELT-like 1 |
224 |
0.92 |
chr2_32741082_32742388 | 9.08 |
Sh2d3c |
SH2 domain containing 3C |
243 |
0.72 |
chr8_124433385_124434495 | 9.06 |
Pgbd5 |
piggyBac transposable element derived 5 |
4 |
0.98 |
chr18_35964551_35965976 | 9.06 |
Psd2 |
pleckstrin and Sec7 domain containing 2 |
158 |
0.94 |
chr7_44592789_44594513 | 9.04 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
344 |
0.69 |
chr2_102400145_102401433 | 9.03 |
Trim44 |
tripartite motif-containing 44 |
111 |
0.98 |
chr5_34186544_34187726 | 8.99 |
Mxd4 |
Max dimerization protein 4 |
575 |
0.58 |
chrX_64275723_64277215 | 8.99 |
Slitrk4 |
SLIT and NTRK-like family, member 4 |
510 |
0.87 |
chr14_5388439_5389375 | 8.97 |
Gm3500 |
predicted gene 3500 |
142 |
0.94 |
chr17_55970296_55971683 | 8.94 |
Shd |
src homology 2 domain-containing transforming protein D |
400 |
0.68 |
chr10_81024569_81025640 | 8.93 |
Gm16099 |
predicted gene 16099 |
21 |
0.8 |
chr2_140395451_140395792 | 8.91 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
26 |
0.98 |
chr1_16518628_16519393 | 8.90 |
Stau2 |
staufen double-stranded RNA binding protein 2 |
201 |
0.95 |
chr8_31089411_31091663 | 8.88 |
Dusp26 |
dual specificity phosphatase 26 (putative) |
733 |
0.65 |
chr2_143547529_143548278 | 8.88 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
66 |
0.97 |
chr14_4726384_4727541 | 8.86 |
Gm3252 |
predicted gene 3252 |
187 |
0.91 |
chr3_89320679_89321987 | 8.84 |
Efna3 |
ephrin A3 |
298 |
0.73 |
chr11_79590775_79591929 | 8.83 |
Rab11fip4 |
RAB11 family interacting protein 4 (class II) |
140 |
0.93 |
chr2_181134042_181135583 | 8.81 |
Kcnq2 |
potassium voltage-gated channel, subfamily Q, member 2 |
110 |
0.95 |
chr9_51765374_51766248 | 8.81 |
Arhgap20 |
Rho GTPase activating protein 20 |
151 |
0.97 |
chr6_42349189_42350019 | 8.78 |
Zyx |
zyxin |
26 |
0.93 |
chr1_132880197_132881455 | 8.77 |
Lrrn2 |
leucine rich repeat protein 2, neuronal |
471 |
0.81 |
chr2_157914223_157915670 | 8.77 |
Vstm2l |
V-set and transmembrane domain containing 2-like |
293 |
0.91 |
chr11_97404417_97405515 | 8.75 |
Arhgap23 |
Rho GTPase activating protein 23 |
10567 |
0.15 |
chr11_97574672_97575211 | 8.73 |
Srcin1 |
SRC kinase signaling inhibitor 1 |
274 |
0.87 |
chr4_129985171_129986191 | 8.72 |
Adgrb2 |
adhesion G protein-coupled receptor B2 |
413 |
0.79 |
chr6_113890285_113891668 | 8.63 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
394 |
0.85 |
chr6_93911862_93913573 | 8.61 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr16_5884597_5886147 | 8.60 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr17_27655153_27656459 | 8.60 |
Pacsin1 |
protein kinase C and casein kinase substrate in neurons 1 |
218 |
0.87 |
chr6_119328752_119331284 | 8.60 |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
739 |
0.43 |
chr8_125897868_125898882 | 8.58 |
Pcnx2 |
pecanex homolog 2 |
58 |
0.88 |
chrX_6171993_6173046 | 8.57 |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
496 |
0.82 |
chr9_58487884_58489303 | 8.55 |
Insyn1 |
inhibitory synaptic factor 1 |
10 |
0.98 |
chr9_106147912_106149765 | 8.54 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
151 |
0.9 |
chr4_148130089_148131325 | 8.46 |
Draxin |
dorsal inhibitory axon guidance protein |
9 |
0.72 |
chr1_34750294_34751404 | 8.45 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
268 |
0.85 |
chr12_112929411_112929629 | 8.43 |
Jag2 |
jagged 2 |
256 |
0.83 |
chr14_79768163_79769199 | 8.42 |
Gm9748 |
predicted gene 9748 |
1227 |
0.37 |
chr14_5501278_5502453 | 8.40 |
Gm3488 |
predicted gene, 3488 |
191 |
0.9 |
chr19_47014128_47015152 | 8.40 |
Ina |
internexin neuronal intermediate filament protein, alpha |
58 |
0.88 |
chr12_112722274_112723056 | 8.39 |
Cep170b |
centrosomal protein 170B |
471 |
0.67 |
chr18_58836090_58837117 | 8.39 |
Adamts19 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 19 |
64 |
0.98 |
chr14_6756399_6757462 | 8.39 |
Gm3636 |
predicted gene 3636 |
14598 |
0.14 |
chr17_47877478_47879368 | 8.33 |
Foxp4 |
forkhead box P4 |
530 |
0.7 |
chr3_105451575_105453095 | 8.32 |
Kcnd3 |
potassium voltage-gated channel, Shal-related family, member 3 |
5 |
0.93 |
chr7_105787540_105788104 | 8.31 |
Dchs1 |
dachsous cadherin related 1 |
168 |
0.9 |
chr12_16653378_16654213 | 8.31 |
Ntsr2 |
neurotensin receptor 2 |
37 |
0.97 |
chr9_45430098_45431532 | 8.30 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
417 |
0.52 |
chr14_34819835_34820684 | 8.27 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
151 |
0.96 |
chr7_46179165_46180456 | 8.25 |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
176 |
0.92 |
chr3_90265133_90265649 | 8.22 |
Dennd4b |
DENN/MADD domain containing 4B |
206 |
0.85 |
chr16_9994378_9995594 | 8.19 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
63 |
0.98 |
chr11_116653200_116654630 | 8.19 |
Prcd |
photoreceptor disc component |
60 |
0.83 |
chr7_6414737_6415889 | 8.18 |
Smim17 |
small integral membrane protein 17 |
138 |
0.89 |
chr7_40898734_40899964 | 8.18 |
Vstm2b |
V-set and transmembrane domain containing 2B |
17 |
0.93 |
chr7_5056231_5057716 | 8.18 |
Gm15510 |
predicted gene 15510 |
53 |
0.48 |
chr15_78770199_78773461 | 8.17 |
Mfng |
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
64 |
0.96 |
chr9_40268795_40270233 | 8.15 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
81 |
0.96 |
chr1_124045018_124046369 | 8.15 |
Dpp10 |
dipeptidylpeptidase 10 |
134 |
0.98 |
chr14_7026733_7027810 | 8.14 |
Gm10406 |
predicted gene 10406 |
178 |
0.93 |
chr4_141367848_141369009 | 8.14 |
Fam131c |
family with sequence similarity 131, member C |
208 |
0.87 |
chr14_5740931_5741933 | 8.12 |
Gm3373 |
predicted gene 3373 |
145 |
0.93 |
chr7_100893244_100895336 | 8.11 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
400 |
0.8 |
chr14_6426291_6427481 | 8.10 |
Lamtor3-ps |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3, pseudogene |
14404 |
0.14 |
chr11_102604334_102605731 | 8.09 |
Fzd2 |
frizzled class receptor 2 |
636 |
0.55 |
chr6_85501969_85503009 | 8.08 |
Fbxo41 |
F-box protein 41 |
369 |
0.8 |
chrX_44367369_44368587 | 8.04 |
Dcaf12l2 |
DDB1 and CUL4 associated factor 12-like 2 |
364 |
0.91 |
chr7_46396141_46398423 | 8.03 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
366 |
0.84 |
chrX_7638310_7639997 | 8.01 |
Syp |
synaptophysin |
152 |
0.88 |
chr7_81454192_81455460 | 8.00 |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
68 |
0.93 |
chr5_110543976_110545228 | 8.00 |
Galnt9 |
polypeptide N-acetylgalactosaminyltransferase 9 |
247 |
0.9 |
chr5_35056488_35057824 | 7.99 |
Dok7 |
docking protein 7 |
79 |
0.96 |
chr6_124996779_124997957 | 7.96 |
Pianp |
PILR alpha associated neural protein |
293 |
0.78 |
chr5_24350886_24351753 | 7.91 |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
285 |
0.82 |
chr1_92847884_92848981 | 7.90 |
Gm29480 |
predicted gene 29480 |
339 |
0.76 |
chr7_81933245_81934293 | 7.89 |
Hdgfl3 |
HDGF like 3 |
254 |
0.88 |
chr16_6348470_6349707 | 7.87 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
50 |
0.99 |
chr4_124658606_124659175 | 7.86 |
Gm2164 |
predicted gene 2164 |
1721 |
0.21 |
chr14_29721838_29722847 | 7.84 |
Cacna2d3 |
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
478 |
0.79 |
chr14_7314401_7315446 | 7.83 |
Gm3739 |
predicted gene 3739 |
126 |
0.95 |
chr6_29396045_29397338 | 7.83 |
Ccdc136 |
coiled-coil domain containing 136 |
6 |
0.53 |
chr17_24488403_24488701 | 7.83 |
Caskin1 |
CASK interacting protein 1 |
49 |
0.92 |
chr14_5148637_5149909 | 7.79 |
Gm3317 |
predicted gene 3317 |
15262 |
0.11 |
chr3_87999404_88000408 | 7.79 |
Bcan |
brevican |
272 |
0.82 |
chr11_68399496_68400824 | 7.79 |
Ntn1 |
netrin 1 |
663 |
0.74 |
chr2_180103356_180104508 | 7.79 |
Hrh3 |
histamine receptor H3 |
219 |
0.89 |
chr7_111778295_111780348 | 7.77 |
Galnt18 |
polypeptide N-acetylgalactosaminyltransferase 18 |
656 |
0.76 |
chr1_136259745_136260967 | 7.75 |
Gpr25 |
G protein-coupled receptor 25 |
517 |
0.54 |
chr1_74771159_74771991 | 7.74 |
Wnt6 |
wingless-type MMTV integration site family, member 6 |
317 |
0.82 |
chr8_123410787_123412789 | 7.74 |
Tubb3 |
tubulin, beta 3 class III |
198 |
0.84 |
chr12_113185913_113186788 | 7.73 |
Tmem121 |
transmembrane protein 121 |
420 |
0.74 |
chr9_44486015_44488913 | 7.73 |
Bcl9l |
B cell CLL/lymphoma 9-like |
217 |
0.81 |
chr9_107231013_107232162 | 7.72 |
Dock3 |
dedicator of cyto-kinesis 3 |
5 |
0.61 |
chr16_18628939_18629866 | 7.71 |
Septin5 |
septin 5 |
302 |
0.83 |
chr7_38107514_38107740 | 7.71 |
Ccne1 |
cyclin E1 |
93 |
0.97 |
chr1_72536044_72537425 | 7.69 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
196 |
0.95 |
chr19_4614601_4615128 | 7.68 |
Lrfn4 |
leucine rich repeat and fibronectin type III domain containing 4 |
638 |
0.57 |
chr8_122335750_122336915 | 7.67 |
Zfpm1 |
zinc finger protein, multitype 1 |
1701 |
0.24 |
chr4_155042413_155043778 | 7.66 |
Plch2 |
phospholipase C, eta 2 |
59 |
0.94 |
chrX_101299067_101300498 | 7.66 |
Nlgn3 |
neuroligin 3 |
572 |
0.58 |
chr11_77930982_77932135 | 7.65 |
Sez6 |
seizure related gene 6 |
519 |
0.68 |
chr15_68362971_68363229 | 7.62 |
Gm20732 |
predicted gene 20732 |
76 |
0.96 |
chr18_34840357_34841683 | 7.61 |
Reep2 |
receptor accessory protein 2 |
431 |
0.77 |
chr9_122571762_122573193 | 7.61 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
22 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 116.7 | GO:0071625 | vocalization behavior(GO:0071625) |
8.6 | 25.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
8.3 | 16.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
7.3 | 7.3 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
6.8 | 20.4 | GO:0021586 | pons maturation(GO:0021586) |
6.3 | 19.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
6.1 | 30.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
6.1 | 12.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
6.0 | 18.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
5.8 | 23.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
5.7 | 17.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
5.6 | 45.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
5.6 | 22.4 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
5.4 | 21.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
5.2 | 10.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
5.1 | 30.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
5.1 | 45.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
5.0 | 5.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
4.9 | 39.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
4.9 | 24.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
4.9 | 14.7 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
4.8 | 14.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
4.7 | 18.8 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
4.7 | 9.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
4.7 | 14.0 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
4.6 | 23.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
4.5 | 22.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
4.5 | 27.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
4.4 | 8.9 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
4.3 | 4.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
4.3 | 8.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
4.3 | 4.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
4.3 | 12.8 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
4.2 | 21.0 | GO:1903276 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
4.1 | 12.2 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
4.1 | 16.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
4.0 | 8.0 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
4.0 | 4.0 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
4.0 | 7.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.9 | 47.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
3.9 | 7.9 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
3.9 | 7.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
3.9 | 19.5 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
3.9 | 15.4 | GO:0030035 | microspike assembly(GO:0030035) |
3.8 | 7.6 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
3.7 | 18.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
3.7 | 22.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
3.7 | 7.4 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
3.7 | 7.4 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
3.7 | 29.5 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
3.6 | 76.6 | GO:0001964 | startle response(GO:0001964) |
3.6 | 10.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
3.6 | 3.6 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
3.6 | 14.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.6 | 14.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
3.6 | 10.7 | GO:0046958 | nonassociative learning(GO:0046958) |
3.6 | 17.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
3.5 | 24.7 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
3.5 | 13.9 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
3.5 | 13.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
3.5 | 24.3 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
3.4 | 3.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
3.3 | 23.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
3.3 | 10.0 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
3.3 | 13.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.3 | 9.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
3.3 | 19.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
3.3 | 19.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
3.3 | 3.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
3.2 | 22.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
3.2 | 16.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
3.2 | 171.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
3.2 | 9.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
3.2 | 6.4 | GO:0050975 | sensory perception of touch(GO:0050975) |
3.2 | 9.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
3.2 | 6.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
3.2 | 3.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
3.2 | 9.5 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
3.2 | 6.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
3.1 | 9.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
3.1 | 9.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
3.1 | 9.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
3.1 | 3.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
3.1 | 9.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
3.1 | 18.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
3.1 | 40.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
3.1 | 9.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
3.1 | 30.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
3.1 | 12.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
3.1 | 9.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
3.0 | 27.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
3.0 | 6.1 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
3.0 | 6.1 | GO:0060166 | olfactory pit development(GO:0060166) |
3.0 | 6.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
3.0 | 3.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
3.0 | 9.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
3.0 | 3.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
3.0 | 15.0 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
3.0 | 8.9 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
3.0 | 5.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
3.0 | 3.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
2.9 | 8.8 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
2.9 | 5.8 | GO:1902837 | amino acid import into cell(GO:1902837) |
2.9 | 14.6 | GO:0035989 | tendon development(GO:0035989) |
2.9 | 11.7 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
2.9 | 2.9 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
2.9 | 17.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
2.9 | 8.7 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
2.9 | 2.9 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
2.8 | 2.8 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
2.8 | 8.5 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
2.8 | 8.4 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
2.8 | 11.2 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
2.8 | 5.6 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
2.8 | 5.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.8 | 5.6 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
2.8 | 8.3 | GO:0044849 | estrous cycle(GO:0044849) |
2.8 | 13.8 | GO:0070842 | aggresome assembly(GO:0070842) |
2.8 | 2.8 | GO:0035106 | operant conditioning(GO:0035106) |
2.8 | 22.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.8 | 5.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.8 | 16.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
2.7 | 5.5 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
2.7 | 8.2 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
2.7 | 13.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
2.7 | 2.7 | GO:0072197 | ureter morphogenesis(GO:0072197) |
2.7 | 5.4 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
2.7 | 16.1 | GO:0003139 | secondary heart field specification(GO:0003139) |
2.7 | 8.0 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
2.7 | 2.7 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
2.7 | 8.0 | GO:0015888 | thiamine transport(GO:0015888) |
2.7 | 10.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
2.7 | 2.7 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
2.6 | 23.8 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
2.6 | 2.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.6 | 2.6 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
2.6 | 7.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
2.6 | 15.8 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
2.6 | 2.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.6 | 2.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
2.6 | 5.2 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
2.6 | 2.6 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
2.6 | 46.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.6 | 25.9 | GO:0060074 | synapse maturation(GO:0060074) |
2.6 | 10.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
2.6 | 15.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
2.6 | 7.7 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
2.6 | 35.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
2.6 | 2.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
2.6 | 2.6 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
2.6 | 12.8 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
2.6 | 5.1 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
2.5 | 12.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
2.5 | 2.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
2.5 | 15.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
2.5 | 17.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
2.5 | 2.5 | GO:0090135 | actin filament branching(GO:0090135) |
2.5 | 25.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
2.5 | 2.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
2.5 | 12.6 | GO:0086014 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
2.5 | 2.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
2.5 | 5.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
2.5 | 10.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
2.5 | 9.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.5 | 9.9 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
2.5 | 5.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
2.5 | 2.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
2.5 | 12.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
2.4 | 4.9 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
2.4 | 4.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
2.4 | 4.9 | GO:0070831 | basement membrane assembly(GO:0070831) |
2.4 | 7.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.4 | 7.3 | GO:1903416 | response to glycoside(GO:1903416) |
2.4 | 26.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
2.4 | 2.4 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
2.4 | 9.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
2.4 | 2.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
2.4 | 19.3 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
2.4 | 7.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.4 | 7.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.4 | 7.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
2.4 | 40.2 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
2.4 | 11.8 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
2.4 | 2.4 | GO:0070672 | response to interleukin-15(GO:0070672) |
2.4 | 4.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
2.3 | 25.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
2.3 | 4.7 | GO:0070384 | Harderian gland development(GO:0070384) |
2.3 | 18.7 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
2.3 | 20.9 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
2.3 | 2.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
2.3 | 4.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.3 | 4.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
2.3 | 6.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.3 | 2.3 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
2.3 | 9.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
2.3 | 9.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
2.3 | 6.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
2.3 | 13.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
2.3 | 2.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
2.3 | 9.1 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
2.3 | 2.3 | GO:0010694 | regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
2.3 | 9.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
2.3 | 6.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
2.3 | 4.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
2.2 | 2.2 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
2.2 | 18.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
2.2 | 11.2 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
2.2 | 6.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.2 | 31.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
2.2 | 4.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
2.2 | 2.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.2 | 6.6 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
2.2 | 4.4 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
2.2 | 4.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
2.2 | 6.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.2 | 17.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
2.2 | 6.6 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
2.2 | 4.4 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
2.2 | 24.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
2.2 | 4.4 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
2.2 | 6.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
2.2 | 2.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
2.2 | 4.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
2.2 | 36.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
2.2 | 2.2 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
2.1 | 8.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.1 | 4.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
2.1 | 6.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
2.1 | 2.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
2.1 | 4.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.1 | 2.1 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
2.1 | 10.5 | GO:0031000 | response to caffeine(GO:0031000) |
2.1 | 16.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
2.1 | 4.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
2.1 | 10.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
2.1 | 4.2 | GO:0032898 | neurotrophin production(GO:0032898) |
2.1 | 4.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
2.1 | 8.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
2.1 | 4.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
2.1 | 2.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
2.1 | 6.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
2.1 | 6.2 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
2.1 | 6.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.1 | 37.3 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
2.1 | 2.1 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
2.1 | 6.2 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
2.1 | 8.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
2.1 | 4.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
2.0 | 10.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
2.0 | 10.2 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
2.0 | 4.1 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
2.0 | 4.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
2.0 | 10.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
2.0 | 8.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
2.0 | 10.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.0 | 6.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
2.0 | 16.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
2.0 | 2.0 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
2.0 | 6.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
2.0 | 6.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
2.0 | 4.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
2.0 | 2.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
2.0 | 5.9 | GO:0030070 | insulin processing(GO:0030070) |
2.0 | 5.9 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
2.0 | 3.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
2.0 | 5.9 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
2.0 | 13.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
2.0 | 2.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
2.0 | 5.9 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
1.9 | 23.4 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.9 | 3.9 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
1.9 | 52.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
1.9 | 5.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.9 | 5.8 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.9 | 5.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
1.9 | 1.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.9 | 5.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.9 | 1.9 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.9 | 49.8 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.9 | 7.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.9 | 5.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.9 | 3.8 | GO:0060174 | limb bud formation(GO:0060174) |
1.9 | 3.8 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.9 | 5.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.9 | 3.8 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
1.9 | 5.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.9 | 3.7 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
1.9 | 7.5 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
1.9 | 181.0 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
1.9 | 1.9 | GO:0048678 | response to axon injury(GO:0048678) |
1.9 | 5.6 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
1.9 | 5.6 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
1.9 | 1.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.8 | 5.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.8 | 1.8 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.8 | 3.7 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
1.8 | 12.8 | GO:1902287 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
1.8 | 10.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.8 | 1.8 | GO:0072553 | terminal button organization(GO:0072553) |
1.8 | 9.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
1.8 | 10.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.8 | 50.6 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
1.8 | 3.6 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
1.8 | 3.6 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
1.8 | 1.8 | GO:0015755 | fructose transport(GO:0015755) |
1.8 | 10.8 | GO:0097264 | self proteolysis(GO:0097264) |
1.8 | 3.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.8 | 9.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.8 | 1.8 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
1.8 | 5.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.8 | 5.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.8 | 1.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.8 | 5.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.8 | 3.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.8 | 3.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.8 | 3.5 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.8 | 7.0 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.8 | 7.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.8 | 5.3 | GO:0015817 | histidine transport(GO:0015817) |
1.8 | 5.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.8 | 5.3 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.8 | 1.8 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.7 | 1.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.7 | 3.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.7 | 1.7 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
1.7 | 5.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.7 | 3.5 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.7 | 7.0 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
1.7 | 8.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.7 | 7.0 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
1.7 | 1.7 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
1.7 | 1.7 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.7 | 3.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.7 | 22.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
1.7 | 5.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
1.7 | 1.7 | GO:1902896 | terminal web assembly(GO:1902896) |
1.7 | 1.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.7 | 5.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
1.7 | 8.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
1.7 | 3.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.7 | 5.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
1.7 | 13.5 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.7 | 1.7 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
1.7 | 1.7 | GO:0021764 | amygdala development(GO:0021764) |
1.7 | 3.4 | GO:0036166 | phenotypic switching(GO:0036166) |
1.7 | 8.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
1.7 | 5.0 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.7 | 5.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
1.7 | 29.9 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
1.7 | 10.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.7 | 5.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.7 | 125.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.6 | 85.6 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
1.6 | 4.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.6 | 3.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.6 | 4.9 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.6 | 1.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.6 | 3.3 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
1.6 | 1.6 | GO:0060746 | parental behavior(GO:0060746) |
1.6 | 3.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
1.6 | 3.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
1.6 | 4.9 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
1.6 | 6.5 | GO:0051775 | response to redox state(GO:0051775) |
1.6 | 4.9 | GO:0001927 | exocyst assembly(GO:0001927) |
1.6 | 11.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
1.6 | 1.6 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
1.6 | 1.6 | GO:0045103 | intermediate filament-based process(GO:0045103) |
1.6 | 8.0 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.6 | 1.6 | GO:0007431 | salivary gland development(GO:0007431) |
1.6 | 1.6 | GO:0035933 | glucocorticoid secretion(GO:0035933) corticosterone secretion(GO:0035934) regulation of glucocorticoid secretion(GO:2000849) regulation of corticosterone secretion(GO:2000852) |
1.6 | 6.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.6 | 4.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.6 | 3.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
1.6 | 33.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
1.6 | 7.9 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
1.6 | 9.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.6 | 15.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
1.6 | 6.3 | GO:0030091 | protein repair(GO:0030091) |
1.6 | 9.4 | GO:0060026 | convergent extension(GO:0060026) |
1.6 | 4.7 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
1.6 | 1.6 | GO:1903748 | negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
1.6 | 15.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.6 | 1.6 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.6 | 20.2 | GO:0007616 | long-term memory(GO:0007616) |
1.5 | 6.2 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
1.5 | 1.5 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
1.5 | 4.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
1.5 | 1.5 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
1.5 | 9.2 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
1.5 | 6.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
1.5 | 1.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.5 | 45.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
1.5 | 1.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
1.5 | 9.0 | GO:0015816 | glycine transport(GO:0015816) |
1.5 | 4.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.5 | 4.5 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.5 | 4.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.5 | 5.9 | GO:0038001 | paracrine signaling(GO:0038001) |
1.5 | 3.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.5 | 3.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.5 | 4.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.5 | 1.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.5 | 2.9 | GO:0032147 | activation of protein kinase activity(GO:0032147) |
1.5 | 2.9 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
1.5 | 4.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
1.5 | 1.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.5 | 4.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
1.4 | 1.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
1.4 | 2.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.4 | 1.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.4 | 15.8 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
1.4 | 7.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.4 | 14.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
1.4 | 2.9 | GO:0030421 | defecation(GO:0030421) |
1.4 | 2.9 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
1.4 | 1.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.4 | 7.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.4 | 4.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.4 | 18.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
1.4 | 4.3 | GO:0030432 | peristalsis(GO:0030432) |
1.4 | 4.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.4 | 7.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
1.4 | 1.4 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.4 | 2.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.4 | 1.4 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
1.4 | 1.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.4 | 5.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
1.4 | 7.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.4 | 4.2 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
1.4 | 9.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.4 | 2.8 | GO:0097009 | energy homeostasis(GO:0097009) |
1.4 | 4.2 | GO:0060437 | lung growth(GO:0060437) |
1.4 | 1.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.4 | 1.4 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
1.4 | 2.8 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.4 | 9.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.4 | 1.4 | GO:0032353 | regulation of glucocorticoid metabolic process(GO:0031943) regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of hormone biosynthetic process(GO:0032353) regulation of cortisol biosynthetic process(GO:2000064) |
1.4 | 5.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.4 | 2.8 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
1.4 | 1.4 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
1.4 | 9.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.4 | 4.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
1.4 | 15.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
1.4 | 4.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.4 | 2.8 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.4 | 5.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.4 | 2.8 | GO:0042891 | antibiotic transport(GO:0042891) |
1.4 | 4.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
1.4 | 15.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.4 | 1.4 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.4 | 13.7 | GO:0002931 | response to ischemia(GO:0002931) |
1.4 | 5.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
1.4 | 1.4 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.4 | 1.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.4 | 1.4 | GO:0098739 | import across plasma membrane(GO:0098739) |
1.4 | 13.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.3 | 1.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
1.3 | 9.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.3 | 1.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.3 | 5.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
1.3 | 4.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.3 | 9.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.3 | 5.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.3 | 2.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.3 | 2.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.3 | 6.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.3 | 9.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.3 | 2.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.3 | 2.6 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
1.3 | 1.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.3 | 2.6 | GO:0015824 | proline transport(GO:0015824) |
1.3 | 5.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
1.3 | 1.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.3 | 1.3 | GO:0046078 | dUMP metabolic process(GO:0046078) |
1.3 | 2.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.3 | 7.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.3 | 5.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
1.3 | 2.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
1.3 | 3.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.3 | 1.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.3 | 7.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.3 | 2.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.3 | 3.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.3 | 3.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.3 | 2.6 | GO:0033227 | dsRNA transport(GO:0033227) |
1.3 | 1.3 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
1.3 | 2.6 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
1.3 | 3.9 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
1.3 | 1.3 | GO:0008078 | mesodermal cell migration(GO:0008078) |
1.3 | 3.8 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.3 | 6.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.3 | 1.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
1.3 | 7.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.3 | 3.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.3 | 2.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.3 | 8.9 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
1.3 | 2.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.3 | 3.8 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
1.3 | 1.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
1.3 | 11.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
1.3 | 3.8 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.3 | 2.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.3 | 8.8 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.3 | 6.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.3 | 3.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.3 | 8.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.3 | 2.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.3 | 7.6 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
1.3 | 5.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.3 | 2.5 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
1.3 | 2.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.3 | 3.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.3 | 36.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
1.3 | 3.8 | GO:0042756 | drinking behavior(GO:0042756) |
1.3 | 6.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.2 | 5.0 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
1.2 | 5.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
1.2 | 2.5 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
1.2 | 8.7 | GO:0006108 | malate metabolic process(GO:0006108) |
1.2 | 1.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.2 | 7.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.2 | 1.2 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
1.2 | 14.8 | GO:0045116 | protein neddylation(GO:0045116) |
1.2 | 4.9 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
1.2 | 3.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.2 | 4.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.2 | 2.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.2 | 24.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
1.2 | 6.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
1.2 | 15.9 | GO:0014850 | response to muscle activity(GO:0014850) |
1.2 | 1.2 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
1.2 | 9.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.2 | 3.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.2 | 3.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.2 | 4.8 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
1.2 | 4.8 | GO:0046541 | saliva secretion(GO:0046541) |
1.2 | 3.6 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
1.2 | 8.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.2 | 6.0 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
1.2 | 18.1 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
1.2 | 3.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.2 | 2.4 | GO:0009629 | response to gravity(GO:0009629) |
1.2 | 6.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.2 | 2.4 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
1.2 | 1.2 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
1.2 | 2.4 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.2 | 18.9 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
1.2 | 1.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.2 | 1.2 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
1.2 | 9.4 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
1.2 | 1.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
1.2 | 1.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.2 | 4.7 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.2 | 1.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.2 | 4.7 | GO:0008228 | opsonization(GO:0008228) |
1.2 | 1.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
1.2 | 2.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
1.2 | 3.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.2 | 2.3 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
1.2 | 2.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.2 | 1.2 | GO:0097320 | membrane tubulation(GO:0097320) |
1.2 | 2.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
1.2 | 3.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.2 | 1.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.2 | 5.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.2 | 13.8 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
1.2 | 3.5 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.1 | 2.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
1.1 | 5.7 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
1.1 | 9.2 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
1.1 | 1.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.1 | 14.9 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
1.1 | 3.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.1 | 18.3 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
1.1 | 10.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.1 | 2.3 | GO:0061198 | fungiform papilla formation(GO:0061198) |
1.1 | 1.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.1 | 2.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.1 | 8.0 | GO:0036065 | fucosylation(GO:0036065) |
1.1 | 3.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.1 | 4.6 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.1 | 1.1 | GO:0014028 | notochord formation(GO:0014028) |
1.1 | 2.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.1 | 4.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.1 | 1.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.1 | 1.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.1 | 4.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
1.1 | 3.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.1 | 4.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
1.1 | 3.4 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.1 | 12.3 | GO:0043248 | proteasome assembly(GO:0043248) |
1.1 | 2.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
1.1 | 2.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.1 | 2.2 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
1.1 | 10.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
1.1 | 8.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
1.1 | 2.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.1 | 2.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.1 | 15.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
1.1 | 3.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.1 | 5.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.1 | 3.3 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
1.1 | 7.7 | GO:0060004 | reflex(GO:0060004) |
1.1 | 12.0 | GO:0046834 | lipid phosphorylation(GO:0046834) phosphatidylinositol phosphorylation(GO:0046854) |
1.1 | 2.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
1.1 | 6.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.1 | 3.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.1 | 2.2 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
1.1 | 2.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
1.1 | 1.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.1 | 4.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.1 | 9.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
1.1 | 2.2 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
1.1 | 14.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
1.1 | 2.2 | GO:0090148 | membrane fission(GO:0090148) |
1.1 | 6.4 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.1 | 1.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
1.1 | 2.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.1 | 6.4 | GO:0015074 | DNA integration(GO:0015074) |
1.1 | 23.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
1.1 | 6.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.1 | 4.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.1 | 6.4 | GO:0051013 | microtubule severing(GO:0051013) |
1.1 | 2.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.1 | 2.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.1 | 4.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
1.1 | 1.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
1.0 | 1.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
1.0 | 6.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.0 | 21.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
1.0 | 5.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
1.0 | 2.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.0 | 2.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
1.0 | 5.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
1.0 | 6.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.0 | 3.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.0 | 3.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.0 | 1.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
1.0 | 3.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.0 | 3.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.0 | 5.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
1.0 | 9.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
1.0 | 4.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.0 | 2.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
1.0 | 5.1 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
1.0 | 2.0 | GO:0006734 | NADH metabolic process(GO:0006734) |
1.0 | 8.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.0 | 10.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
1.0 | 2.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
1.0 | 5.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.0 | 4.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
1.0 | 6.1 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
1.0 | 11.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
1.0 | 1.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
1.0 | 1.0 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
1.0 | 1.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.0 | 2.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
1.0 | 4.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.0 | 1.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.0 | 7.0 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
1.0 | 4.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.0 | 6.9 | GO:0036314 | response to sterol(GO:0036314) |
1.0 | 17.8 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
1.0 | 3.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.0 | 3.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
1.0 | 2.9 | GO:0097531 | mast cell migration(GO:0097531) |
1.0 | 46.1 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
1.0 | 5.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
1.0 | 1.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.0 | 2.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
1.0 | 4.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
1.0 | 3.9 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
1.0 | 4.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.0 | 2.9 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
1.0 | 6.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.0 | 2.9 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.0 | 1.9 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.0 | 1.9 | GO:0019228 | neuronal action potential(GO:0019228) |
1.0 | 5.8 | GO:0031103 | axon regeneration(GO:0031103) |
1.0 | 2.9 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
1.0 | 1.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.0 | 1.0 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
1.0 | 1.9 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
1.0 | 5.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.0 | 1.9 | GO:0051639 | actin filament network formation(GO:0051639) |
1.0 | 4.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.0 | 7.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.0 | 1.0 | GO:0032271 | regulation of protein polymerization(GO:0032271) |
1.0 | 1.9 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
1.0 | 6.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.0 | 1.0 | GO:0035973 | aggrephagy(GO:0035973) |
1.0 | 9.5 | GO:0045056 | transcytosis(GO:0045056) |
1.0 | 1.9 | GO:0007525 | somatic muscle development(GO:0007525) |
1.0 | 3.8 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
1.0 | 3.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.9 | 1.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.9 | 2.8 | GO:0080009 | mRNA methylation(GO:0080009) |
0.9 | 0.9 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.9 | 1.9 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.9 | 17.9 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.9 | 7.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.9 | 1.9 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.9 | 0.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.9 | 0.9 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.9 | 5.6 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.9 | 13.1 | GO:0008542 | visual learning(GO:0008542) |
0.9 | 1.9 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.9 | 4.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.9 | 3.7 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.9 | 0.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.9 | 3.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.9 | 6.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.9 | 0.9 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.9 | 5.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.9 | 2.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.9 | 1.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.9 | 2.8 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.9 | 8.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.9 | 3.7 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.9 | 2.8 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.9 | 1.9 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.9 | 8.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.9 | 1.8 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.9 | 1.8 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.9 | 1.8 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.9 | 1.8 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.9 | 4.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.9 | 7.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.9 | 0.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.9 | 4.6 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.9 | 0.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.9 | 2.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.9 | 1.8 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.9 | 3.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.9 | 1.8 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.9 | 2.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.9 | 4.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.9 | 5.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.9 | 14.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.9 | 8.9 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.9 | 1.8 | GO:0015819 | lysine transport(GO:0015819) |
0.9 | 1.8 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.9 | 0.9 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.9 | 0.9 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.9 | 1.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.9 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
0.9 | 3.5 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.9 | 0.9 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.9 | 4.4 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.9 | 2.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.9 | 4.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.9 | 0.9 | GO:0006971 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
0.9 | 1.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.9 | 4.4 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.9 | 2.6 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.9 | 1.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.9 | 1.7 | GO:0060306 | regulation of membrane repolarization(GO:0060306) |
0.9 | 26.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.9 | 8.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.9 | 1.7 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.9 | 3.5 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.9 | 0.9 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.9 | 2.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.9 | 3.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.9 | 0.9 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.9 | 32.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.9 | 0.9 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.9 | 6.0 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.9 | 3.4 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.9 | 2.6 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.9 | 17.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.9 | 3.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.9 | 1.7 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.9 | 0.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.8 | 4.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.8 | 2.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.8 | 4.2 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.8 | 28.6 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.8 | 0.8 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.8 | 30.1 | GO:0050804 | modulation of synaptic transmission(GO:0050804) |
0.8 | 1.7 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.8 | 4.2 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.8 | 2.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.8 | 0.8 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.8 | 6.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.8 | 4.1 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.8 | 1.7 | GO:1901660 | calcium ion export(GO:1901660) |
0.8 | 0.8 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.8 | 2.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.8 | 4.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.8 | 1.6 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.8 | 0.8 | GO:0051661 | maintenance of centrosome location(GO:0051661) maintenance of Golgi location(GO:0051684) |
0.8 | 1.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.8 | 12.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.8 | 5.7 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.8 | 4.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.8 | 0.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.8 | 5.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.8 | 1.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.8 | 2.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.8 | 1.6 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.8 | 2.4 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.8 | 4.0 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.8 | 0.8 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.8 | 12.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.8 | 2.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.8 | 2.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.8 | 2.4 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.8 | 1.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.8 | 12.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.8 | 1.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.8 | 3.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.8 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 0.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.8 | 0.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.8 | 8.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.8 | 5.5 | GO:0032288 | myelin assembly(GO:0032288) |
0.8 | 0.8 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.8 | 7.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.8 | 4.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.8 | 0.8 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.8 | 2.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.8 | 6.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.8 | 1.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.8 | 1.6 | GO:0051665 | membrane raft localization(GO:0051665) |
0.8 | 3.9 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.8 | 1.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.8 | 0.8 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.8 | 3.9 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.8 | 3.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.8 | 1.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.8 | 1.5 | GO:0042255 | ribosome assembly(GO:0042255) |
0.8 | 2.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.8 | 4.6 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.8 | 4.6 | GO:0014002 | astrocyte development(GO:0014002) |
0.8 | 0.8 | GO:1901563 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.8 | 7.7 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.8 | 2.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.8 | 0.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.8 | 39.4 | GO:0036503 | ERAD pathway(GO:0036503) |
0.8 | 3.8 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.8 | 1.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.8 | 31.8 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.8 | 0.8 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.8 | 0.8 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.8 | 2.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.8 | 1.5 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.8 | 7.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.7 | 8.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.7 | 6.0 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.7 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.7 | 2.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.7 | 0.7 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.7 | 7.5 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.7 | 3.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.7 | 3.7 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.7 | 0.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.7 | 5.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.7 | 21.6 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.7 | 5.2 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.7 | 3.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.7 | 8.9 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.7 | 8.1 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.7 | 3.0 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.7 | 14.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.7 | 1.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.7 | 2.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.7 | 2.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.7 | 2.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 1.5 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.7 | 1.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.7 | 0.7 | GO:0002159 | desmosome assembly(GO:0002159) |
0.7 | 2.9 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.7 | 0.7 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.7 | 1.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.7 | 1.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.7 | 26.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.7 | 2.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.7 | 0.7 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.7 | 2.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.7 | 2.2 | GO:0010447 | response to acidic pH(GO:0010447) |
0.7 | 2.2 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.7 | 11.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 1.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 1.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.7 | 5.7 | GO:0032094 | response to food(GO:0032094) |
0.7 | 1.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.7 | 9.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.7 | 2.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.7 | 10.0 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.7 | 0.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.7 | 2.1 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.7 | 5.0 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.7 | 0.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.7 | 11.4 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.7 | 1.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.7 | 0.7 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.7 | 1.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.7 | 1.4 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.7 | 0.7 | GO:0070417 | cellular response to cold(GO:0070417) |
0.7 | 0.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.7 | 3.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.7 | 2.8 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.7 | 1.4 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.7 | 2.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.7 | 2.8 | GO:0042637 | catagen(GO:0042637) |
0.7 | 2.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.7 | 1.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.7 | 0.7 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.7 | 0.7 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
0.7 | 0.7 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.7 | 0.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.7 | 0.7 | GO:0072665 | protein localization to vacuole(GO:0072665) |
0.7 | 0.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.7 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.7 | 7.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.7 | 2.1 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.7 | 1.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.7 | 3.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.7 | 10.3 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.7 | 2.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.7 | 0.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.7 | 4.1 | GO:0009268 | response to pH(GO:0009268) |
0.7 | 2.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.7 | 4.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.7 | 2.0 | GO:0015867 | ATP transport(GO:0015867) |
0.7 | 5.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.7 | 2.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.7 | 9.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.7 | 1.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.7 | 0.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.7 | 0.7 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.7 | 1.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.7 | 1.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.7 | 2.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.7 | 0.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.7 | 1.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.7 | 0.7 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.7 | 11.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.7 | 9.3 | GO:0021766 | hippocampus development(GO:0021766) |
0.7 | 2.6 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.7 | 1.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.7 | 2.6 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.7 | 2.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.7 | 0.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.7 | 4.6 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.7 | 2.0 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.7 | 0.7 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.7 | 0.7 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.7 | 23.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.7 | 0.7 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.7 | 2.0 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.7 | 5.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.7 | 3.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.7 | 2.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.6 | 1.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.6 | 0.6 | GO:0019042 | viral latency(GO:0019042) |
0.6 | 5.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.6 | 2.6 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.6 | 2.6 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.6 | 3.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.6 | 1.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.6 | 0.6 | GO:0060073 | micturition(GO:0060073) |
0.6 | 0.6 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.6 | 0.6 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.6 | 1.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.6 | 1.3 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.6 | 1.9 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.6 | 1.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.6 | 2.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.6 | 2.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.6 | 2.5 | GO:0009650 | UV protection(GO:0009650) |
0.6 | 1.9 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.6 | 5.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.6 | 1.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 1.9 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.6 | 2.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.6 | 1.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.6 | 7.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.6 | 3.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.6 | 9.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.6 | 0.6 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.6 | 1.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.6 | 1.3 | GO:0001508 | action potential(GO:0001508) |
0.6 | 1.9 | GO:0007031 | peroxisome organization(GO:0007031) |
0.6 | 3.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.6 | 2.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.6 | 5.6 | GO:0015844 | monoamine transport(GO:0015844) |
0.6 | 8.1 | GO:0006497 | protein lipidation(GO:0006497) |
0.6 | 0.6 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.6 | 2.5 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.6 | 1.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.6 | 0.6 | GO:0002339 | B cell selection(GO:0002339) |
0.6 | 6.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.6 | 1.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.6 | 1.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.6 | 1.2 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.6 | 6.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.6 | 3.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.6 | 7.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.6 | 1.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.6 | 0.6 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.6 | 0.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.6 | 147.2 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.6 | 1.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.6 | 1.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 0.6 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.6 | 4.8 | GO:0032355 | response to estradiol(GO:0032355) |
0.6 | 2.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.6 | 2.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.6 | 0.6 | GO:0043092 | L-amino acid import(GO:0043092) |
0.6 | 2.3 | GO:0032049 | cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) |
0.6 | 1.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.6 | 1.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.6 | 0.6 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.6 | 7.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.6 | 5.8 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.6 | 3.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.6 | 1.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.6 | 0.6 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.6 | 1.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.6 | 1.7 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.6 | 5.7 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.6 | 0.6 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.6 | 0.6 | GO:0033865 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.6 | 9.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.6 | 1.7 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.6 | 3.4 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.6 | 0.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.6 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.6 | 2.8 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.6 | 0.6 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.6 | 1.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.6 | 4.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.6 | 3.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.6 | 7.3 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.6 | 1.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.6 | 1.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.6 | 6.7 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.6 | 2.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.6 | 3.9 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.6 | 62.5 | GO:0042384 | cilium assembly(GO:0042384) |
0.6 | 1.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.6 | 1.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 49.5 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.6 | 1.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.6 | 7.8 | GO:0051262 | protein tetramerization(GO:0051262) |
0.6 | 1.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.6 | 5.0 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.6 | 1.7 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 3.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.6 | 0.6 | GO:0060157 | urinary bladder development(GO:0060157) |
0.6 | 2.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.5 | 0.5 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.5 | 0.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.5 | 2.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 1.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.5 | 10.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.5 | 1.6 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 8.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.5 | 3.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.5 | 2.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 1.1 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.5 | 14.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.5 | 2.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.5 | 3.2 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.5 | 0.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.5 | 2.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 8.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 0.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.5 | 2.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.5 | 10.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.5 | 1.1 | GO:0008292 | acetylcholine metabolic process(GO:0008291) acetylcholine biosynthetic process(GO:0008292) acetate ester metabolic process(GO:1900619) acetate ester biosynthetic process(GO:1900620) |
0.5 | 1.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.5 | 1.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.5 | 5.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.5 | 12.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.5 | 1.1 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.5 | 18.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.5 | 1.1 | GO:0008306 | associative learning(GO:0008306) |
0.5 | 1.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.5 | 1.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.5 | 0.5 | GO:0070509 | calcium ion import(GO:0070509) |
0.5 | 0.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 0.5 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.5 | 3.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.5 | 0.5 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.5 | 2.6 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.5 | 1.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.5 | 5.3 | GO:0034397 | telomere localization(GO:0034397) |
0.5 | 5.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.5 | 2.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 4.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.5 | 2.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.5 | 0.5 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.5 | 3.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.5 | 2.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.5 | 0.5 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.5 | 0.5 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.5 | 8.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.5 | 0.5 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.5 | 1.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.5 | 1.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.5 | 2.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.5 | 3.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.5 | 3.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.5 | 1.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.5 | 2.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 1.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.5 | 25.0 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.5 | 1.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.5 | 0.5 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.5 | 1.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.5 | 4.5 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.5 | 2.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 15.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.5 | 1.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 2.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.5 | 0.5 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.5 | 2.0 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.5 | 0.5 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.5 | 1.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.5 | 0.5 | GO:0090383 | phagosome acidification(GO:0090383) |
0.5 | 3.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.5 | 7.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.5 | 1.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.5 | 0.5 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.5 | 0.5 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.5 | 1.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 1.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.5 | 1.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.5 | 3.3 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.5 | 5.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.5 | 1.4 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.5 | 4.3 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.5 | 1.4 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.5 | 3.8 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.5 | 0.9 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.5 | 0.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 0.9 | GO:0048743 | regulation of skeletal muscle fiber development(GO:0048742) positive regulation of skeletal muscle fiber development(GO:0048743) |
0.5 | 3.7 | GO:0022900 | electron transport chain(GO:0022900) |
0.5 | 0.5 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.5 | 0.5 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.5 | 0.5 | GO:0019068 | virion assembly(GO:0019068) |
0.5 | 0.9 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.5 | 7.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.5 | 2.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.5 | 1.9 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.5 | 0.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.5 | 2.3 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.5 | 0.5 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 6.4 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.5 | 1.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.5 | 1.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.5 | 2.8 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.5 | 2.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.5 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.5 | 0.5 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.5 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
0.5 | 1.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.5 | 0.9 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.5 | 0.9 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.5 | 2.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.5 | 0.9 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.5 | 0.9 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.5 | 1.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.5 | 1.8 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.5 | 0.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.5 | 8.6 | GO:0006414 | translational elongation(GO:0006414) |
0.5 | 0.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.5 | 1.4 | GO:0042755 | eating behavior(GO:0042755) |
0.5 | 2.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.5 | 1.8 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.5 | 1.8 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.4 | 1.3 | GO:0032506 | cytokinetic process(GO:0032506) |
0.4 | 1.3 | GO:0002035 | regulation of blood volume by renin-angiotensin(GO:0002016) brain renin-angiotensin system(GO:0002035) |
0.4 | 3.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.4 | 0.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.4 | 7.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.4 | 2.7 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.4 | 0.9 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 3.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 1.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.4 | 10.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.4 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 0.9 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.4 | 0.9 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
0.4 | 2.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 3.0 | GO:0007032 | endosome organization(GO:0007032) |
0.4 | 0.9 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.4 | 0.9 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.4 | 4.4 | GO:0044782 | cilium organization(GO:0044782) |
0.4 | 5.2 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.4 | 0.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.4 | 1.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.4 | 0.4 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.4 | 3.0 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.4 | 2.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.4 | 2.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.4 | 1.3 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.4 | 1.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.4 | 0.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 0.4 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.4 | 0.4 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.4 | 6.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.4 | 0.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.4 | 2.5 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.4 | 0.4 | GO:0098869 | cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.4 | 0.8 | GO:0010522 | regulation of calcium ion transport into cytosol(GO:0010522) |
0.4 | 3.8 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.4 | 0.8 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.4 | 3.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.4 | 3.0 | GO:0042407 | cristae formation(GO:0042407) |
0.4 | 1.7 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.4 | 6.8 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
0.4 | 2.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 0.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 | 2.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 1.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.4 | 3.8 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.4 | 0.8 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.4 | 0.4 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) negative regulation of isotype switching(GO:0045829) |
0.4 | 0.8 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.4 | 1.7 | GO:0042181 | ketone biosynthetic process(GO:0042181) |
0.4 | 1.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 0.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 1.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.4 | 1.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 1.2 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.4 | 0.4 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 0.8 | GO:0044003 | modification by symbiont of host morphology or physiology(GO:0044003) |
0.4 | 4.5 | GO:0045010 | actin nucleation(GO:0045010) |
0.4 | 0.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 9.0 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.4 | 1.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.4 | 0.8 | GO:0061084 | negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.4 | 4.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.4 | 4.9 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.4 | 3.2 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.4 | 0.8 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.4 | 0.8 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 2.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 1.6 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.4 | 2.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.4 | 0.4 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.4 | 0.4 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.4 | 0.8 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.4 | 0.4 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.4 | 2.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.4 | 0.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.4 | 0.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.4 | 0.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 28.2 | GO:0098779 | macromitophagy(GO:0000423) mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.4 | 0.8 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.4 | 1.2 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.4 | 0.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.4 | 3.2 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.4 | 0.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.4 | 2.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 0.4 | GO:0032328 | alanine transport(GO:0032328) |
0.4 | 7.0 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.4 | 3.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.4 | 1.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.4 | 1.2 | GO:0051231 | spindle elongation(GO:0051231) |
0.4 | 1.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 0.4 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.4 | 2.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 1.5 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.4 | 3.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 3.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.4 | 1.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.4 | 0.4 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.4 | 1.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.4 | 12.5 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.4 | 1.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.4 | 0.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.4 | 1.9 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.4 | 0.4 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.4 | 7.5 | GO:0006821 | chloride transport(GO:0006821) |
0.4 | 0.4 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.4 | 0.4 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.4 | 2.6 | GO:0098661 | inorganic anion transmembrane transport(GO:0098661) |
0.4 | 1.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 3.0 | GO:0022406 | membrane docking(GO:0022406) |
0.4 | 0.7 | GO:0034393 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.4 | 1.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.4 | 7.8 | GO:0007034 | vacuolar transport(GO:0007034) |
0.4 | 0.7 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.4 | 0.7 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.4 | 1.9 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.4 | 0.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 2.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 1.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 0.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 3.7 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.4 | 0.7 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.4 | 1.1 | GO:0016577 | histone demethylation(GO:0016577) |
0.4 | 0.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 1.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.4 | 1.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 1.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 1.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.4 | 5.7 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.4 | 6.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.4 | 1.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.4 | 0.4 | GO:0072529 | pyrimidine-containing compound catabolic process(GO:0072529) |
0.4 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.4 | 1.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.4 | 6.7 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.4 | 0.7 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.4 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.4 | 5.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 7.4 | GO:0048017 | inositol lipid-mediated signaling(GO:0048017) |
0.4 | 0.4 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 0.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.4 | 0.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 0.7 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.4 | 1.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.4 | 1.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.4 | 0.7 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 1.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.3 | 1.4 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.3 | 1.4 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.3 | 6.2 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.3 | 0.3 | GO:0014889 | muscle atrophy(GO:0014889) |
0.3 | 0.7 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.3 | 4.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 7.8 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.3 | 9.2 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.3 | 1.0 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.3 | 0.3 | GO:0070266 | necroptotic process(GO:0070266) |
0.3 | 1.7 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.3 | 0.3 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 1.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.3 | 0.7 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.3 | 1.0 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.3 | 1.0 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.3 | 0.7 | GO:0033572 | transferrin transport(GO:0033572) |
0.3 | 2.6 | GO:0007588 | excretion(GO:0007588) |
0.3 | 0.3 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 0.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 1.0 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 1.0 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 0.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.3 | 1.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 0.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.3 | 4.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 0.3 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.3 | 2.6 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.3 | 1.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 7.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 0.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 1.9 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.3 | 0.3 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.3 | 0.3 | GO:0009838 | abscission(GO:0009838) |
0.3 | 0.9 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 0.9 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 1.6 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.3 | 1.9 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.3 | 0.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.3 | 0.3 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 2.8 | GO:0060612 | adipose tissue development(GO:0060612) |
0.3 | 1.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.3 | 1.8 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.3 | 1.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 4.6 | GO:0035329 | hippo signaling(GO:0035329) |
0.3 | 0.9 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.3 | 0.3 | GO:0035268 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.3 | 1.8 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.3 | 2.1 | GO:0070542 | response to fatty acid(GO:0070542) |
0.3 | 1.2 | GO:0033143 | regulation of intracellular steroid hormone receptor signaling pathway(GO:0033143) |
0.3 | 0.9 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 0.6 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.3 | 1.5 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.3 | 0.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.3 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 1.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.3 | 9.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 1.2 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.3 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 1.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.3 | 0.9 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 0.3 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.3 | 1.7 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.3 | 2.0 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.3 | 1.2 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.3 | 25.4 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.3 | 0.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.3 | 1.1 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.3 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.3 | GO:0032392 | DNA geometric change(GO:0032392) |
0.3 | 5.9 | GO:0070613 | regulation of protein processing(GO:0070613) |
0.3 | 1.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 0.8 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.6 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.3 | 0.3 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.3 | 3.3 | GO:0007602 | phototransduction(GO:0007602) |
0.3 | 2.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.3 | 5.0 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.3 | 2.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 1.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.3 | 2.5 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.3 | 0.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 3.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.3 | 3.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 0.3 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.3 | 2.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 0.8 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.3 | 0.3 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.3 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.9 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.3 | 4.3 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 0.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 0.3 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.3 | 2.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.3 | 1.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 0.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 0.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 1.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 40.0 | GO:0007017 | microtubule-based process(GO:0007017) |
0.3 | 0.5 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 2.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.3 | 0.8 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.3 | 7.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.3 | 0.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.3 | 1.8 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.3 | 0.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.3 | 9.9 | GO:0006457 | protein folding(GO:0006457) |
0.3 | 1.0 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.3 | 0.5 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.3 | 1.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 1.0 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.3 | 1.8 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 0.5 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.2 | 1.5 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.2 | 0.2 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 0.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 2.2 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.2 | 1.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 0.5 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 11.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.2 | 2.7 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.2 | 2.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 2.6 | GO:0002792 | negative regulation of peptide secretion(GO:0002792) negative regulation of insulin secretion(GO:0046676) |
0.2 | 3.6 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.2 | 0.2 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.2 | 1.9 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 1.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.5 | GO:1902932 | positive regulation of alcohol biosynthetic process(GO:1902932) |
0.2 | 0.5 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 1.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 2.0 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 4.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 0.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 6.5 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.2 | 1.9 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.2 | 0.2 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 0.8 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
0.2 | 0.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.4 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.6 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
0.2 | 0.8 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 3.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 1.8 | GO:1905037 | autophagosome organization(GO:1905037) |
0.2 | 0.6 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.2 | 9.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.2 | 3.7 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 4.0 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.2 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.2 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.2 | 0.8 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 1.4 | GO:0015992 | proton transport(GO:0015992) |
0.2 | 1.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.2 | 1.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 4.2 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.2 | 5.0 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.2 | 0.6 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.2 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.4 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) nucleoside salvage(GO:0043174) |
0.2 | 1.5 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.2 | 0.7 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) |
0.2 | 0.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.5 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.2 | 0.4 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.2 | 0.7 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 0.4 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.2 | 1.6 | GO:0000910 | cytokinesis(GO:0000910) |
0.2 | 0.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.2 | 1.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 1.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.2 | 4.2 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
0.2 | 0.2 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.2 | 1.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.3 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.2 | 17.0 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.2 | 0.2 | GO:0098900 | regulation of action potential(GO:0098900) |
0.2 | 0.2 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.2 | 1.1 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 1.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.5 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.2 | 1.0 | GO:0030814 | regulation of cAMP metabolic process(GO:0030814) |
0.2 | 1.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.5 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.2 | 0.5 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 0.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.5 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.2 | 2.0 | GO:0016575 | histone deacetylation(GO:0016575) |
0.2 | 2.5 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.2 | 0.2 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 22.4 | GO:0007010 | cytoskeleton organization(GO:0007010) |
0.2 | 0.9 | GO:0001832 | blastocyst growth(GO:0001832) |
0.2 | 0.6 | GO:0007595 | lactation(GO:0007595) |
0.2 | 0.2 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.1 | 1.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0014909 | smooth muscle cell migration(GO:0014909) |
0.1 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 1.7 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 1.3 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.1 | GO:0061337 | cardiac conduction(GO:0061337) |
0.1 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.8 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.4 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 1.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 1.4 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.1 | 0.5 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 0.1 | GO:0031644 | regulation of neurological system process(GO:0031644) |
0.1 | 1.0 | GO:0046939 | nucleotide phosphorylation(GO:0046939) |
0.1 | 0.5 | GO:0042559 | folic acid-containing compound biosynthetic process(GO:0009396) pteridine-containing compound biosynthetic process(GO:0042559) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.2 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.7 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.1 | 0.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.3 | GO:0014904 | myotube cell development(GO:0014904) |
0.1 | 0.8 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 0.1 | GO:0009132 | nucleoside diphosphate metabolic process(GO:0009132) |
0.1 | 0.7 | GO:0070838 | divalent metal ion transport(GO:0070838) |
0.1 | 0.2 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 0.2 | GO:0015846 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.7 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.3 | GO:0072527 | pyrimidine-containing compound metabolic process(GO:0072527) |
0.1 | 0.4 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.1 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.1 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 2.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.4 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.3 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 1.2 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.1 | 0.3 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 1.2 | GO:0006874 | cellular calcium ion homeostasis(GO:0006874) |
0.1 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.5 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 0.2 | GO:0043624 | cellular protein complex disassembly(GO:0043624) |
0.1 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 1.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 1.6 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.1 | 0.1 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.4 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.1 | 0.1 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.1 | 0.3 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.4 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 75.0 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.1 | 0.1 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
0.1 | 0.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.2 | GO:0043501 | regulation of skeletal muscle adaptation(GO:0014733) skeletal muscle adaptation(GO:0043501) |
0.1 | 0.1 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.1 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.1 | 0.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.0 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.0 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.3 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.0 | GO:0097242 | beta-amyloid clearance(GO:0097242) regulation of beta-amyloid clearance(GO:1900221) |
0.0 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.1 | GO:0000279 | M phase(GO:0000279) |
0.0 | 0.0 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.0 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.0 | GO:0044724 | single-organism carbohydrate catabolic process(GO:0044724) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.0 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.0 | 0.1 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
0.0 | 0.0 | GO:0072608 | interleukin-10 secretion(GO:0072608) |
0.0 | 0.2 | GO:0099587 | inorganic cation import into cell(GO:0098659) inorganic ion import into cell(GO:0099587) |
0.0 | 0.1 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.0 | GO:0044786 | nuclear DNA replication(GO:0033260) cell cycle DNA replication(GO:0044786) |
0.0 | 0.0 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0006900 | membrane budding(GO:0006900) |
0.0 | 1.2 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.1 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.0 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.0 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.0 | 0.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.0 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.0 | 0.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.1 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.1 | GO:0019098 | reproductive behavior(GO:0019098) |
0.0 | 0.0 | GO:0002858 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.0 | 0.0 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.0 | GO:0007618 | mating(GO:0007618) |
0.0 | 0.1 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.0 | 0.0 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.0 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
0.0 | 0.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 8.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
8.5 | 8.5 | GO:0005883 | neurofilament(GO:0005883) |
8.1 | 24.2 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
7.2 | 50.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
6.8 | 41.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
5.3 | 57.9 | GO:0043194 | axon initial segment(GO:0043194) |
4.6 | 13.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
4.3 | 34.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
4.1 | 20.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
4.0 | 47.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
4.0 | 75.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
4.0 | 91.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
3.9 | 7.8 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
3.9 | 11.7 | GO:0044393 | microspike(GO:0044393) |
3.8 | 15.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
3.7 | 15.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
3.7 | 3.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
3.6 | 101.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
3.6 | 100.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
3.3 | 19.7 | GO:0097470 | ribbon synapse(GO:0097470) |
3.3 | 13.0 | GO:0045298 | tubulin complex(GO:0045298) |
3.2 | 44.9 | GO:0071565 | nBAF complex(GO:0071565) |
3.2 | 105.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
3.2 | 47.5 | GO:0032590 | dendrite membrane(GO:0032590) |
3.1 | 9.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.0 | 9.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
3.0 | 75.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
3.0 | 9.0 | GO:0097443 | sorting endosome(GO:0097443) |
2.9 | 2.9 | GO:0044298 | cell body membrane(GO:0044298) |
2.9 | 11.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
2.9 | 8.7 | GO:0072534 | perineuronal net(GO:0072534) |
2.9 | 5.8 | GO:0000322 | storage vacuole(GO:0000322) |
2.9 | 158.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
2.8 | 11.1 | GO:0016342 | catenin complex(GO:0016342) |
2.8 | 8.3 | GO:0048179 | activin receptor complex(GO:0048179) |
2.7 | 13.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.7 | 5.4 | GO:1990635 | proximal dendrite(GO:1990635) |
2.7 | 26.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
2.6 | 10.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.6 | 5.3 | GO:0032280 | symmetric synapse(GO:0032280) |
2.6 | 7.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
2.5 | 7.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
2.5 | 22.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.5 | 49.5 | GO:0044295 | axonal growth cone(GO:0044295) |
2.5 | 4.9 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.4 | 2.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
2.4 | 12.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.4 | 332.2 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
2.3 | 21.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
2.3 | 30.2 | GO:0060076 | excitatory synapse(GO:0060076) |
2.3 | 2.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
2.3 | 6.8 | GO:0097513 | myosin II filament(GO:0097513) |
2.2 | 8.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.1 | 4.2 | GO:0034705 | potassium channel complex(GO:0034705) |
2.1 | 12.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
2.1 | 6.2 | GO:0071953 | elastic fiber(GO:0071953) |
2.1 | 6.2 | GO:0042583 | chromaffin granule(GO:0042583) |
2.0 | 6.0 | GO:0001939 | female pronucleus(GO:0001939) male pronucleus(GO:0001940) |
2.0 | 8.0 | GO:0032584 | growth cone membrane(GO:0032584) |
2.0 | 22.0 | GO:0001527 | microfibril(GO:0001527) |
2.0 | 11.8 | GO:0045180 | basal cortex(GO:0045180) |
2.0 | 17.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
2.0 | 3.9 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
2.0 | 7.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.9 | 1.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.9 | 7.6 | GO:0072487 | MSL complex(GO:0072487) |
1.9 | 5.7 | GO:0071564 | npBAF complex(GO:0071564) |
1.9 | 3.8 | GO:0097427 | microtubule bundle(GO:0097427) |
1.9 | 5.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.9 | 22.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.9 | 11.2 | GO:0005915 | zonula adherens(GO:0005915) |
1.9 | 7.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.9 | 11.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.8 | 1.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.8 | 209.8 | GO:0097060 | synaptic membrane(GO:0097060) |
1.8 | 5.4 | GO:0036396 | MIS complex(GO:0036396) |
1.8 | 3.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.8 | 8.8 | GO:0000235 | astral microtubule(GO:0000235) |
1.8 | 5.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.7 | 1.7 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
1.7 | 52.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
1.7 | 127.5 | GO:0030426 | growth cone(GO:0030426) |
1.7 | 1.7 | GO:0030056 | hemidesmosome(GO:0030056) |
1.7 | 5.1 | GO:0043511 | inhibin complex(GO:0043511) |
1.7 | 16.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.7 | 3.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.6 | 19.8 | GO:0034704 | calcium channel complex(GO:0034704) |
1.6 | 1.6 | GO:0044308 | axonal spine(GO:0044308) |
1.6 | 23.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.6 | 4.9 | GO:0001891 | phagocytic cup(GO:0001891) |
1.6 | 6.5 | GO:0030891 | VCB complex(GO:0030891) |
1.6 | 11.3 | GO:0043198 | dendritic shaft(GO:0043198) |
1.6 | 3.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
1.6 | 26.8 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.6 | 4.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.6 | 4.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.5 | 4.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.5 | 4.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.5 | 4.6 | GO:0071797 | LUBAC complex(GO:0071797) |
1.5 | 6.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.5 | 6.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.5 | 6.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.5 | 4.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
1.5 | 5.9 | GO:0043083 | synaptic cleft(GO:0043083) |
1.5 | 55.7 | GO:0043197 | dendritic spine(GO:0043197) |
1.5 | 5.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.4 | 24.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.4 | 1.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.4 | 4.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.4 | 20.1 | GO:0030914 | STAGA complex(GO:0030914) |
1.4 | 4.3 | GO:0032437 | cuticular plate(GO:0032437) |
1.4 | 11.5 | GO:0042587 | glycogen granule(GO:0042587) |
1.4 | 82.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
1.4 | 1.4 | GO:0097422 | tubular endosome(GO:0097422) |
1.4 | 1.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.4 | 50.5 | GO:0043195 | terminal bouton(GO:0043195) |
1.4 | 5.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.4 | 4.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.3 | 6.7 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
1.3 | 2.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.3 | 9.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.3 | 2.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.3 | 21.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.3 | 3.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.3 | 3.9 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.3 | 1.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
1.3 | 11.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.3 | 3.8 | GO:0043293 | apoptosome(GO:0043293) |
1.2 | 27.4 | GO:0034707 | chloride channel complex(GO:0034707) |
1.2 | 1.2 | GO:0000125 | PCAF complex(GO:0000125) |
1.2 | 2.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.2 | 4.9 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.2 | 3.6 | GO:0031417 | NatC complex(GO:0031417) |
1.2 | 6.0 | GO:0005827 | polar microtubule(GO:0005827) |
1.2 | 141.0 | GO:0045202 | synapse(GO:0045202) |
1.2 | 7.0 | GO:0044292 | dendrite terminus(GO:0044292) |
1.2 | 4.7 | GO:0033503 | HULC complex(GO:0033503) |
1.2 | 4.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.2 | 3.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.2 | 3.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.1 | 1.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.1 | 10.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
1.1 | 3.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.1 | 4.5 | GO:0000938 | GARP complex(GO:0000938) |
1.1 | 20.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.1 | 6.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.1 | 2.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.1 | 25.2 | GO:0030315 | T-tubule(GO:0030315) |
1.1 | 1.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.1 | 10.9 | GO:0031519 | PcG protein complex(GO:0031519) |
1.1 | 11.9 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
1.1 | 2.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.1 | 21.7 | GO:0043679 | axon terminus(GO:0043679) |
1.1 | 40.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
1.1 | 2.1 | GO:0001652 | granular component(GO:0001652) |
1.1 | 4.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.1 | 6.4 | GO:0060091 | kinocilium(GO:0060091) |
1.1 | 49.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.1 | 7.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.1 | 8.4 | GO:0000124 | SAGA complex(GO:0000124) |
1.1 | 4.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.0 | 5.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.0 | 7.2 | GO:0033263 | CORVET complex(GO:0033263) |
1.0 | 3.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.0 | 7.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
1.0 | 7.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
1.0 | 2.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.0 | 8.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.0 | 2.0 | GO:0030135 | coated vesicle(GO:0030135) |
1.0 | 14.3 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
1.0 | 4.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.0 | 1.0 | GO:0000812 | Swr1 complex(GO:0000812) |
1.0 | 4.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.0 | 8.1 | GO:0030904 | retromer complex(GO:0030904) |
1.0 | 4.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.0 | 3.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
1.0 | 7.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.0 | 6.0 | GO:0030008 | TRAPP complex(GO:0030008) |
1.0 | 7.0 | GO:0043235 | receptor complex(GO:0043235) |
1.0 | 19.9 | GO:0031901 | early endosome membrane(GO:0031901) |
1.0 | 3.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.0 | 6.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.0 | 103.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
1.0 | 3.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.0 | 2.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.0 | 5.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.0 | 37.1 | GO:0005901 | caveola(GO:0005901) |
1.0 | 10.7 | GO:0035102 | PRC1 complex(GO:0035102) |
1.0 | 1.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.0 | 16.4 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
1.0 | 1.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.0 | 37.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.0 | 14.4 | GO:0031201 | SNARE complex(GO:0031201) |
1.0 | 4.8 | GO:0089701 | U2AF(GO:0089701) |
1.0 | 1.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
1.0 | 17.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
1.0 | 6.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.9 | 24.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.9 | 2.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.9 | 4.7 | GO:0043203 | axon hillock(GO:0043203) |
0.9 | 17.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.9 | 8.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.9 | 12.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.9 | 8.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.9 | 2.8 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.9 | 3.7 | GO:0097433 | dense body(GO:0097433) |
0.9 | 34.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.9 | 5.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.9 | 28.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.9 | 2.7 | GO:0043196 | varicosity(GO:0043196) |
0.9 | 3.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.9 | 40.9 | GO:0042641 | actomyosin(GO:0042641) |
0.9 | 2.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.9 | 9.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.9 | 11.8 | GO:0000145 | exocyst(GO:0000145) |
0.9 | 2.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.9 | 8.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.9 | 1.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.9 | 1.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.9 | 29.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.9 | 4.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.9 | 0.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.9 | 1.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.9 | 2.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.9 | 7.9 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.9 | 17.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.9 | 14.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.9 | 0.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.9 | 13.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.9 | 4.4 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.9 | 2.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.9 | 1.7 | GO:1990357 | terminal web(GO:1990357) |
0.9 | 8.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.9 | 35.3 | GO:0043204 | perikaryon(GO:0043204) |
0.9 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.9 | 9.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.9 | 6.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.9 | 20.5 | GO:0016607 | nuclear speck(GO:0016607) |
0.9 | 6.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.9 | 41.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.8 | 5.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.8 | 22.7 | GO:0005921 | gap junction(GO:0005921) |
0.8 | 261.2 | GO:0043005 | neuron projection(GO:0043005) |
0.8 | 1.7 | GO:0045178 | basal part of cell(GO:0045178) |
0.8 | 6.7 | GO:0002102 | podosome(GO:0002102) |
0.8 | 0.8 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.8 | 3.3 | GO:0032021 | NELF complex(GO:0032021) |
0.8 | 4.1 | GO:0000805 | X chromosome(GO:0000805) |
0.8 | 2.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.8 | 6.5 | GO:0043034 | costamere(GO:0043034) |
0.8 | 5.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.8 | 24.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.8 | 4.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.8 | 2.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.8 | 34.6 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.8 | 4.8 | GO:0097546 | ciliary base(GO:0097546) |
0.8 | 7.1 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.8 | 0.8 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.8 | 6.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.8 | 4.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.8 | 3.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.8 | 5.5 | GO:0031430 | M band(GO:0031430) |
0.8 | 27.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.8 | 6.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.8 | 2.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.8 | 10.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.8 | 75.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.8 | 2.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.8 | 2.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.8 | 2.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.8 | 13.0 | GO:0031902 | late endosome membrane(GO:0031902) |
0.8 | 200.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.8 | 2.3 | GO:0071942 | XPC complex(GO:0071942) |
0.7 | 14.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.7 | 5.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.7 | 1.5 | GO:0005767 | secondary lysosome(GO:0005767) |
0.7 | 2.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.7 | 0.7 | GO:0070938 | contractile ring(GO:0070938) |
0.7 | 15.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.7 | 65.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.7 | 2.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 2.2 | GO:0071546 | pi-body(GO:0071546) |
0.7 | 0.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.7 | 32.5 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.7 | 50.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.7 | 4.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.7 | 1.4 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.7 | 6.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.7 | 15.5 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.7 | 3.5 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.7 | 1.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 45.8 | GO:0005769 | early endosome(GO:0005769) |
0.7 | 4.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.7 | 1.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.7 | 17.2 | GO:0005776 | autophagosome(GO:0005776) |
0.7 | 6.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.7 | 34.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.7 | 2.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.7 | 4.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.7 | 3.3 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 459.3 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.7 | 17.9 | GO:0005770 | late endosome(GO:0005770) |
0.7 | 2.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.7 | 0.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.7 | 21.5 | GO:0005912 | adherens junction(GO:0005912) |
0.7 | 7.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.6 | 3.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.6 | 0.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.6 | 1.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.6 | 1.3 | GO:0090544 | BAF-type complex(GO:0090544) |
0.6 | 3.2 | GO:0070187 | telosome(GO:0070187) |
0.6 | 1.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.6 | 11.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.6 | 4.4 | GO:0099568 | cytoplasmic region(GO:0099568) |
0.6 | 5.6 | GO:0005902 | microvillus(GO:0005902) |
0.6 | 3.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.6 | 4.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.6 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.6 | 2.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.6 | 1.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 3.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.6 | 6.1 | GO:0030133 | transport vesicle(GO:0030133) |
0.6 | 3.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.6 | 7.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.6 | 1.8 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.6 | 4.8 | GO:0005884 | actin filament(GO:0005884) |
0.6 | 4.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.6 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.6 | 13.5 | GO:0097458 | neuron part(GO:0097458) |
0.6 | 5.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.6 | 81.0 | GO:0005874 | microtubule(GO:0005874) |
0.6 | 1.2 | GO:0072686 | mitotic spindle(GO:0072686) |
0.6 | 9.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.6 | 1.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.6 | 25.2 | GO:0001726 | ruffle(GO:0001726) |
0.6 | 4.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 0.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.6 | 4.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.6 | 2.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.6 | 5.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.6 | 1.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.6 | 9.4 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.6 | 1.7 | GO:0030496 | midbody(GO:0030496) |
0.6 | 25.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.5 | 3.3 | GO:0000801 | central element(GO:0000801) |
0.5 | 3.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 35.0 | GO:0005768 | endosome(GO:0005768) |
0.5 | 2.7 | GO:0005657 | replication fork(GO:0005657) |
0.5 | 1.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.5 | 1.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.5 | 1.6 | GO:0002177 | manchette(GO:0002177) |
0.5 | 1.6 | GO:0045120 | pronucleus(GO:0045120) |
0.5 | 3.7 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.5 | 37.6 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.5 | 2.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.5 | 1.6 | GO:0097228 | sperm principal piece(GO:0097228) |
0.5 | 13.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.5 | 3.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.5 | 1.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.5 | 1.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.5 | 2.0 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.5 | 4.6 | GO:0010369 | chromocenter(GO:0010369) |
0.5 | 1.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 2.5 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.5 | 4.5 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.5 | 2.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.5 | 2.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.5 | 2.0 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.5 | 71.4 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.5 | 2.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 1.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.5 | 5.3 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.5 | 1.9 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.5 | 2.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.5 | 1.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 2.9 | GO:0051233 | spindle midzone(GO:0051233) |
0.5 | 19.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.5 | 0.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 39.3 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.5 | 1.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.5 | 1.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.5 | 7.9 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.5 | 2.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 6.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.5 | 3.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.5 | 3.2 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.5 | 1.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.5 | 48.6 | GO:0005929 | cilium(GO:0005929) |
0.5 | 2.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.5 | 12.7 | GO:0045177 | apical part of cell(GO:0045177) |
0.5 | 2.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.5 | 0.9 | GO:0030689 | Noc complex(GO:0030689) |
0.4 | 2.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 0.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.4 | 1.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.4 | 1.8 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 2.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.4 | 2.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 5.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.4 | 78.3 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.4 | 1.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.4 | 13.4 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 3.9 | GO:0000800 | lateral element(GO:0000800) |
0.4 | 11.4 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.4 | 2.5 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 1.7 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 0.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.4 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 12.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 1.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.4 | 9.4 | GO:0030018 | Z disc(GO:0030018) |
0.4 | 4.0 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 1.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 4.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.4 | 2.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 9.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 1.6 | GO:0031082 | BLOC complex(GO:0031082) |
0.4 | 12.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.4 | 60.6 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.4 | 1412.5 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.4 | 10.1 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.4 | 1.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 1.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.4 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.4 | 7.1 | GO:0005840 | ribosome(GO:0005840) |
0.4 | 0.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.4 | 27.2 | GO:0097708 | intracellular vesicle(GO:0097708) |
0.4 | 8.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 14.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.4 | 2.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 3.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.4 | 1.4 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 3.9 | GO:1990391 | DNA repair complex(GO:1990391) |
0.4 | 6.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 1.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 1.0 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.3 | 190.5 | GO:0005886 | plasma membrane(GO:0005886) |
0.3 | 8.9 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 4.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.3 | 0.3 | GO:0044297 | cell body(GO:0044297) |
0.3 | 2.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 12.7 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.3 | 10.1 | GO:0044429 | mitochondrial part(GO:0044429) |
0.3 | 1.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 3.9 | GO:0009986 | cell surface(GO:0009986) |
0.3 | 1.9 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.3 | 0.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 10.7 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.3 | 0.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 5.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.3 | 3.7 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 3.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 0.9 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 0.9 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.3 | 1.2 | GO:0000922 | spindle pole(GO:0000922) |
0.3 | 2.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 1.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 113.6 | GO:0005829 | cytosol(GO:0005829) |
0.3 | 4.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 7.7 | GO:0012505 | endomembrane system(GO:0012505) |
0.3 | 1.4 | GO:0031674 | I band(GO:0031674) |
0.3 | 0.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 159.5 | GO:0016020 | membrane(GO:0016020) |
0.3 | 0.3 | GO:0030894 | replisome(GO:0030894) |
0.3 | 0.3 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.3 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.0 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.5 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.2 | 92.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.6 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.2 | 1.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 1.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 1.7 | GO:0031252 | cell leading edge(GO:0031252) |
0.2 | 3.0 | GO:0042995 | cell projection(GO:0042995) |
0.2 | 240.4 | GO:0005576 | extracellular region(GO:0005576) |
0.2 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 1.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 1.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 2.1 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 17.0 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 214.1 | GO:0005737 | cytoplasm(GO:0005737) |
0.1 | 3.4 | GO:0099513 | supramolecular fiber(GO:0099512) polymeric cytoskeletal fiber(GO:0099513) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.0 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.5 | 31.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
8.2 | 24.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
7.3 | 21.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
7.2 | 21.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
6.8 | 20.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
6.6 | 19.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
6.6 | 19.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
6.4 | 25.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
6.0 | 29.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
5.7 | 11.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
5.5 | 16.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
5.5 | 21.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
5.3 | 15.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
5.2 | 10.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
4.8 | 14.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
4.7 | 14.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
4.7 | 37.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
4.6 | 23.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
4.6 | 9.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
4.4 | 22.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
4.4 | 13.1 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
4.3 | 4.3 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
4.2 | 16.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
4.0 | 12.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
3.9 | 11.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.9 | 7.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
3.9 | 19.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
3.8 | 3.8 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
3.8 | 11.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
3.8 | 71.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
3.8 | 7.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
3.7 | 14.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
3.7 | 29.6 | GO:0008066 | glutamate receptor activity(GO:0008066) |
3.7 | 29.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
3.6 | 10.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.5 | 14.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
3.5 | 3.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
3.5 | 7.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
3.4 | 17.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
3.4 | 3.4 | GO:0038191 | neuropilin binding(GO:0038191) |
3.4 | 16.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
3.3 | 33.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
3.3 | 13.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
3.2 | 13.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
3.2 | 12.9 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
3.2 | 15.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
3.1 | 3.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
3.1 | 12.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
3.1 | 91.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
3.0 | 12.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
3.0 | 9.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
3.0 | 12.0 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
3.0 | 8.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
3.0 | 29.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
3.0 | 8.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.9 | 11.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.9 | 8.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.9 | 2.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
2.9 | 14.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
2.9 | 23.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.9 | 11.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
2.9 | 14.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.9 | 8.6 | GO:2001070 | starch binding(GO:2001070) |
2.8 | 5.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
2.8 | 5.7 | GO:0051380 | norepinephrine binding(GO:0051380) |
2.8 | 5.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.8 | 19.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
2.8 | 11.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.8 | 5.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
2.8 | 8.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
2.7 | 5.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
2.7 | 10.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.7 | 2.7 | GO:0030371 | translation repressor activity(GO:0030371) |
2.6 | 58.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
2.6 | 52.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
2.6 | 23.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.6 | 7.9 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
2.6 | 13.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
2.6 | 5.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
2.6 | 46.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
2.6 | 5.1 | GO:0043398 | HLH domain binding(GO:0043398) |
2.5 | 10.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
2.5 | 22.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
2.5 | 45.3 | GO:0005112 | Notch binding(GO:0005112) |
2.5 | 10.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.5 | 12.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
2.5 | 14.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
2.4 | 9.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
2.4 | 12.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
2.4 | 4.8 | GO:0005522 | profilin binding(GO:0005522) |
2.4 | 9.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.4 | 7.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
2.4 | 9.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.4 | 7.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.4 | 11.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
2.3 | 9.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.3 | 9.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
2.3 | 25.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
2.3 | 59.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
2.3 | 6.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
2.3 | 11.5 | GO:0045545 | syndecan binding(GO:0045545) |
2.3 | 20.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.3 | 2.3 | GO:0004359 | glutaminase activity(GO:0004359) |
2.3 | 11.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
2.3 | 9.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
2.2 | 2.2 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
2.2 | 42.5 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
2.2 | 6.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.2 | 31.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
2.2 | 19.9 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
2.2 | 19.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
2.2 | 50.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
2.2 | 6.6 | GO:0035939 | microsatellite binding(GO:0035939) |
2.2 | 30.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
2.2 | 26.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
2.2 | 8.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
2.1 | 16.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
2.1 | 21.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
2.1 | 25.2 | GO:0031402 | sodium ion binding(GO:0031402) |
2.1 | 6.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.1 | 6.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
2.1 | 12.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
2.1 | 41.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.1 | 60.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
2.1 | 6.2 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
2.0 | 24.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
2.0 | 2.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.0 | 14.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
2.0 | 6.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.0 | 20.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
2.0 | 6.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.0 | 22.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
2.0 | 20.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
2.0 | 24.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
2.0 | 6.0 | GO:0008142 | oxysterol binding(GO:0008142) |
2.0 | 6.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
2.0 | 11.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.0 | 9.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.0 | 11.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.0 | 9.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.9 | 15.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.9 | 9.6 | GO:0048495 | Roundabout binding(GO:0048495) |
1.9 | 13.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.9 | 5.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.9 | 13.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.9 | 7.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.9 | 22.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.9 | 1.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.9 | 5.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.9 | 7.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.9 | 1.9 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.9 | 7.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.9 | 3.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.9 | 9.3 | GO:0016775 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
1.9 | 44.7 | GO:0050699 | WW domain binding(GO:0050699) |
1.8 | 20.3 | GO:0015643 | toxic substance binding(GO:0015643) |
1.8 | 3.7 | GO:0097016 | L27 domain binding(GO:0097016) |
1.8 | 12.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.8 | 7.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.8 | 3.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.8 | 12.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.8 | 5.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.8 | 5.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.8 | 23.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.8 | 18.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
1.8 | 3.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.8 | 37.6 | GO:0045296 | cadherin binding(GO:0045296) |
1.8 | 35.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.8 | 39.1 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
1.8 | 7.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.8 | 7.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.8 | 5.3 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
1.8 | 28.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
1.8 | 5.3 | GO:0043559 | insulin binding(GO:0043559) |
1.7 | 5.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.7 | 10.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
1.7 | 45.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.7 | 10.4 | GO:0051219 | phosphoprotein binding(GO:0051219) |
1.7 | 15.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.7 | 6.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.7 | 5.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.7 | 10.2 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.7 | 5.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.7 | 43.9 | GO:0030507 | spectrin binding(GO:0030507) |
1.7 | 5.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
1.7 | 1.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.7 | 6.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
1.7 | 5.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.7 | 45.3 | GO:0019894 | kinesin binding(GO:0019894) |
1.7 | 3.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.7 | 51.6 | GO:0004629 | phospholipase C activity(GO:0004629) |
1.7 | 9.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.6 | 18.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.6 | 8.2 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
1.6 | 4.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.6 | 56.6 | GO:0030276 | clathrin binding(GO:0030276) |
1.6 | 3.2 | GO:0017040 | ceramidase activity(GO:0017040) |
1.6 | 4.8 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.6 | 14.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.6 | 3.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.6 | 3.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.6 | 1.6 | GO:0050780 | dopamine receptor binding(GO:0050780) |
1.6 | 4.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.6 | 3.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
1.6 | 15.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
1.6 | 4.7 | GO:0030955 | potassium ion binding(GO:0030955) |
1.6 | 14.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.6 | 37.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.6 | 9.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.6 | 14.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
1.6 | 3.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
1.6 | 3.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.5 | 6.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.5 | 18.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.5 | 13.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.5 | 24.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.5 | 7.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.5 | 3.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.5 | 13.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.5 | 4.5 | GO:0089720 | caspase binding(GO:0089720) |
1.5 | 5.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
1.5 | 4.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.5 | 8.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.5 | 1.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.5 | 7.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.5 | 19.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
1.5 | 1.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
1.5 | 7.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.5 | 4.4 | GO:0070052 | collagen V binding(GO:0070052) |
1.5 | 7.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.5 | 16.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
1.4 | 8.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.4 | 7.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.4 | 4.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.4 | 4.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.4 | 2.8 | GO:0042805 | actinin binding(GO:0042805) |
1.4 | 1.4 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
1.4 | 16.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
1.4 | 12.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.4 | 4.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.4 | 29.1 | GO:0030332 | cyclin binding(GO:0030332) |
1.4 | 2.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.4 | 4.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.4 | 2.8 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.4 | 4.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.4 | 51.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
1.4 | 4.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.4 | 4.1 | GO:0019002 | GMP binding(GO:0019002) |
1.3 | 4.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.3 | 8.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.3 | 24.2 | GO:0003785 | actin monomer binding(GO:0003785) |
1.3 | 6.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.3 | 1.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
1.3 | 1.3 | GO:0035198 | miRNA binding(GO:0035198) |
1.3 | 2.7 | GO:1990188 | euchromatin binding(GO:1990188) |
1.3 | 16.0 | GO:0005272 | sodium channel activity(GO:0005272) |
1.3 | 13.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.3 | 11.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.3 | 2.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.3 | 14.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
1.3 | 5.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.3 | 3.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.3 | 2.6 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.3 | 5.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.3 | 10.3 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
1.3 | 6.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.3 | 14.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
1.3 | 3.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.3 | 5.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.3 | 14.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.3 | 6.4 | GO:0034711 | inhibin binding(GO:0034711) |
1.3 | 10.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.3 | 3.8 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.3 | 7.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.3 | 3.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.3 | 13.8 | GO:0031005 | filamin binding(GO:0031005) |
1.2 | 24.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.2 | 3.7 | GO:0016015 | morphogen activity(GO:0016015) |
1.2 | 80.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
1.2 | 7.4 | GO:0070403 | NAD+ binding(GO:0070403) |
1.2 | 7.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.2 | 1.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.2 | 13.4 | GO:0008252 | nucleotidase activity(GO:0008252) |
1.2 | 1.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.2 | 26.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.2 | 23.1 | GO:0044654 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
1.2 | 6.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.2 | 12.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
1.2 | 3.6 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.2 | 13.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.2 | 2.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.2 | 40.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
1.2 | 4.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.2 | 2.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.2 | 1.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.2 | 7.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.2 | 6.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.2 | 4.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.2 | 1.2 | GO:0050693 | LBD domain binding(GO:0050693) |
1.2 | 20.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.2 | 39.0 | GO:0016247 | channel regulator activity(GO:0016247) |
1.2 | 1.2 | GO:0070492 | disaccharide binding(GO:0048030) oligosaccharide binding(GO:0070492) |
1.2 | 2.4 | GO:2001069 | glycogen binding(GO:2001069) |
1.2 | 41.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.2 | 3.5 | GO:0030275 | LRR domain binding(GO:0030275) |
1.2 | 3.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.2 | 12.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.2 | 8.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.2 | 3.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.2 | 2.3 | GO:0070905 | serine binding(GO:0070905) |
1.2 | 8.1 | GO:0034785 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.2 | 7.0 | GO:0005216 | ion channel activity(GO:0005216) |
1.2 | 3.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.2 | 4.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.2 | 11.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.2 | 2.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
1.2 | 1.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
1.2 | 5.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.1 | 4.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.1 | 1.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
1.1 | 4.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.1 | 4.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.1 | 5.7 | GO:0043426 | MRF binding(GO:0043426) |
1.1 | 4.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.1 | 3.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.1 | 97.8 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
1.1 | 15.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.1 | 112.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.1 | 11.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
1.1 | 3.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.1 | 10.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.1 | 20.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
1.1 | 4.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.1 | 3.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.1 | 4.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.1 | 2.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.1 | 11.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.1 | 4.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.1 | 6.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
1.1 | 4.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.1 | 1.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.1 | 4.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.1 | 1.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.1 | 31.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
1.1 | 11.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.1 | 1.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
1.1 | 8.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.1 | 2.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.1 | 1.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
1.1 | 6.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.0 | 2.1 | GO:0051425 | PTB domain binding(GO:0051425) |
1.0 | 5.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.0 | 1.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.0 | 4.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.0 | 26.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
1.0 | 4.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.0 | 17.7 | GO:0042562 | hormone binding(GO:0042562) |
1.0 | 14.6 | GO:0043864 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
1.0 | 3.1 | GO:0034452 | dynactin binding(GO:0034452) |
1.0 | 9.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
1.0 | 5.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.0 | 5.2 | GO:0033265 | choline binding(GO:0033265) |
1.0 | 3.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.0 | 2.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.0 | 18.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.0 | 11.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.0 | 49.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
1.0 | 2.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.0 | 3.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
1.0 | 2.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.0 | 2.0 | GO:0071253 | connexin binding(GO:0071253) |
1.0 | 3.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.0 | 2.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.0 | 2.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.0 | 41.8 | GO:0044325 | ion channel binding(GO:0044325) |
1.0 | 19.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.0 | 4.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.0 | 10.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.0 | 1.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
1.0 | 3.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.0 | 3.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.0 | 13.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.0 | 8.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.0 | 1.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.0 | 2.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.0 | 1.0 | GO:0016298 | lipase activity(GO:0016298) |
1.0 | 2.9 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
1.0 | 1.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
1.0 | 3.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.0 | 1.0 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.0 | 4.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.0 | 39.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
1.0 | 2.9 | GO:0048156 | tau protein binding(GO:0048156) |
1.0 | 5.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
1.0 | 1.9 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.0 | 1.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.0 | 3.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.0 | 6.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.0 | 2.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.9 | 3.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.9 | 15.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.9 | 8.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.9 | 23.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.9 | 0.9 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.9 | 4.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.9 | 0.9 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.9 | 7.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.9 | 2.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.9 | 3.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.9 | 3.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.9 | 5.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.9 | 38.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.9 | 1.9 | GO:0015928 | fucosidase activity(GO:0015928) |
0.9 | 12.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.9 | 2.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.9 | 2.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.9 | 2.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.9 | 2.8 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.9 | 5.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.9 | 6.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.9 | 9.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.9 | 3.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.9 | 1.8 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.9 | 12.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.9 | 2.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.9 | 5.5 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.9 | 1.8 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.9 | 0.9 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.9 | 17.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.9 | 8.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.9 | 0.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.9 | 0.9 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.9 | 1.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.9 | 7.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.9 | 3.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.9 | 11.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.9 | 9.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.9 | 10.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.9 | 16.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.9 | 2.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.9 | 3.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.9 | 2.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.9 | 1.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.9 | 20.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.9 | 5.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.9 | 8.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.9 | 2.6 | GO:0019117 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.9 | 47.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.9 | 1.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.9 | 1.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.9 | 0.9 | GO:0042731 | PH domain binding(GO:0042731) |
0.9 | 0.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.9 | 1.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.9 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.9 | 3.4 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.8 | 0.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.8 | 11.7 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.8 | 9.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.8 | 16.5 | GO:0019798 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) procollagen-proline dioxygenase activity(GO:0019798) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.8 | 0.8 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.8 | 4.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.8 | 0.8 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.8 | 2.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.8 | 5.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.8 | 2.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.8 | 136.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.8 | 9.7 | GO:0005521 | lamin binding(GO:0005521) |
0.8 | 1.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.8 | 0.8 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.8 | 0.8 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.8 | 4.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.8 | 15.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.8 | 3.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.8 | 3.1 | GO:0019003 | GDP binding(GO:0019003) |
0.8 | 24.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.8 | 2.3 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.8 | 1.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.8 | 3.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.8 | 11.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.8 | 3.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.8 | 0.8 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.8 | 3.0 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.8 | 43.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.8 | 0.8 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.8 | 60.2 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.7 | 4.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.7 | 3.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.7 | 4.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.7 | 86.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.7 | 28.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.7 | 2.2 | GO:0004096 | catalase activity(GO:0004096) |
0.7 | 2.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.7 | 2.9 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.7 | 2.9 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.7 | 34.9 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.7 | 6.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.7 | 2.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 5.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 2.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.7 | 5.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.7 | 0.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.7 | 1.4 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.7 | 32.9 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.7 | 2.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 2.1 | GO:0019961 | interferon binding(GO:0019961) |
0.7 | 17.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.7 | 2.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.7 | 6.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.7 | 24.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.7 | 6.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.7 | 12.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.7 | 3.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.7 | 0.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.7 | 2.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.7 | 3.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.7 | 5.6 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.7 | 9.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.7 | 11.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.7 | 2.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.7 | 7.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.7 | 24.8 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.7 | 3.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.7 | 1.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.7 | 1.4 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.7 | 38.4 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.7 | 2.7 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.7 | 8.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.7 | 210.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.7 | 4.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.7 | 2.7 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.7 | 7.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.7 | 2.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.7 | 2.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.7 | 4.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.7 | 7.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.7 | 1.3 | GO:0009374 | biotin binding(GO:0009374) |
0.7 | 2.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.7 | 4.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.7 | 2.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.7 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.7 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.7 | 15.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.6 | 1.9 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.6 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.6 | 3.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.6 | 2.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.6 | 9.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.6 | 10.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.6 | 1.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.6 | 1.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.6 | 2.6 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.6 | 44.7 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.6 | 159.0 | GO:0005525 | GTP binding(GO:0005525) |
0.6 | 1.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.6 | 1.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.6 | 21.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.6 | 3.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.6 | 9.4 | GO:0030594 | neurotransmitter receptor activity(GO:0030594) |
0.6 | 10.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 1.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.6 | 5.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.6 | 3.7 | GO:0048038 | quinone binding(GO:0048038) |
0.6 | 10.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.6 | 1.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.6 | 1.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.6 | 3.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 4.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.6 | 6.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.6 | 1.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.6 | 0.6 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.6 | 1.8 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.6 | 2.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.6 | 7.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.6 | 1.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.6 | 15.1 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.6 | 3.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.6 | 1.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.6 | 12.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.6 | 2.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.6 | 5.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.6 | 4.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.6 | 4.1 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.6 | 0.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.6 | 0.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 2.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.6 | 1.2 | GO:0036122 | BMP binding(GO:0036122) |
0.6 | 1.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 6.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.6 | 8.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.6 | 10.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.6 | 16.0 | GO:0015631 | tubulin binding(GO:0015631) |
0.6 | 7.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.6 | 9.1 | GO:0043621 | protein self-association(GO:0043621) |
0.6 | 2.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.6 | 20.3 | GO:0051020 | GTPase binding(GO:0051020) |
0.6 | 0.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 14.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.6 | 1.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.6 | 5.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.6 | 11.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.6 | 6.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.6 | 6.1 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.6 | 1.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.6 | 1.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.6 | 1.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.6 | 3.9 | GO:0000339 | RNA cap binding(GO:0000339) |
0.6 | 2.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.6 | 1.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.6 | 6.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 1.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.5 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 0.5 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.5 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.5 | 1.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 2.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 17.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.5 | 4.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.5 | 1.6 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.5 | 1.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 6.9 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.5 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 2.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 1.6 | GO:0043918 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.5 | 3.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.5 | 43.0 | GO:0003729 | mRNA binding(GO:0003729) |
0.5 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 1.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.5 | 1.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.5 | 13.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.5 | 1.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.5 | 1.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.5 | 1.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.5 | 2.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.5 | 8.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.5 | 3.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.5 | 1.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.5 | 2.0 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.5 | 1.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 2.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.5 | 1.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.5 | 6.6 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.5 | 1.5 | GO:0002054 | nucleobase binding(GO:0002054) |
0.5 | 7.6 | GO:0005518 | collagen binding(GO:0005518) |
0.5 | 1.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 1.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.5 | 0.5 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.5 | 1.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 4.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.5 | 1.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.5 | 16.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.5 | 1.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 1.5 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.5 | 0.5 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.5 | 1.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 0.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.5 | 5.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.5 | 0.5 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.5 | 2.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 11.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.5 | 22.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.5 | 2.4 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.5 | 1.9 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.5 | 78.0 | GO:0003779 | actin binding(GO:0003779) |
0.5 | 2.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.5 | 9.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.5 | 2.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 4.1 | GO:0008061 | chitin binding(GO:0008061) |
0.5 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 2.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.5 | 5.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.5 | 1.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.5 | 1.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 9.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.4 | 1.8 | GO:0009055 | electron carrier activity(GO:0009055) |
0.4 | 4.0 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.4 | 3.6 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.4 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 0.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.4 | 4.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 0.9 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.4 | 8.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.4 | 12.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.4 | 7.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.4 | 3.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.4 | 0.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 2.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.4 | 2.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 14.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 2.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.4 | 1.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.4 | 0.4 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.4 | 3.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.4 | 6.0 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.4 | 0.9 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.4 | 2.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 0.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 1.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 0.4 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.4 | 0.8 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 0.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 3.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.4 | 2.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.4 | 7.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.4 | 0.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.4 | 0.8 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.4 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.4 | 5.0 | GO:0019905 | syntaxin binding(GO:0019905) |
0.4 | 0.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.4 | 0.4 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.4 | 2.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 0.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.4 | 0.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 2.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.4 | 1.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.4 | 3.2 | GO:0045502 | dynein binding(GO:0045502) |
0.4 | 3.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 0.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.4 | 7.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 2.3 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.4 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 4.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.4 | 5.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.4 | 0.8 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.4 | 0.8 | GO:0032183 | SUMO binding(GO:0032183) |
0.4 | 30.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.4 | 11.1 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.4 | 1.9 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.4 | 2.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 7.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 3.4 | GO:0000149 | SNARE binding(GO:0000149) |
0.4 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.4 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 1.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 12.9 | GO:0008092 | cytoskeletal protein binding(GO:0008092) |
0.4 | 22.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 0.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 1.4 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.4 | 1.4 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 0.4 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 2.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 2.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 4.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 0.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.3 | 1.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 0.7 | GO:0015103 | inorganic anion transmembrane transporter activity(GO:0015103) |
0.3 | 2.0 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 1.7 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 1.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 17.6 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.3 | 1.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 10.5 | GO:0002020 | protease binding(GO:0002020) |
0.3 | 0.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 1.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 3.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 0.3 | GO:0046873 | metal ion transmembrane transporter activity(GO:0046873) |
0.3 | 10.3 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.3 | 6.5 | GO:0005516 | calmodulin binding(GO:0005516) |
0.3 | 19.2 | GO:0003723 | RNA binding(GO:0003723) |
0.3 | 4.6 | GO:0051287 | NAD binding(GO:0051287) |
0.3 | 0.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 0.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.3 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 0.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.3 | 0.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 8.3 | GO:0005496 | steroid binding(GO:0005496) |
0.3 | 3.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 0.6 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.3 | 4.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 0.6 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.3 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 4.6 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.3 | 1.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 0.9 | GO:0016208 | AMP binding(GO:0016208) |
0.3 | 0.3 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.3 | 0.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 0.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 7.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 1.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 1.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 1.4 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.3 | 11.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 2.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.3 | 0.8 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 0.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 17.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 2.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 10.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.3 | 0.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.3 | 4.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 9.5 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.3 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 1.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 0.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.3 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 0.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 13.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.3 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 5.5 | GO:0005254 | chloride channel activity(GO:0005254) |
0.2 | 3.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.2 | 2.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 6.4 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 14.4 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.2 | 7.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 1.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.2 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 4.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 2.0 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.2 | 9.9 | GO:0008289 | lipid binding(GO:0008289) |
0.2 | 0.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 93.1 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.2 | 1.4 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.2 | 1.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 7.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 0.7 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.2 | 4.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 40.8 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.2 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 1.8 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.4 | GO:0016853 | isomerase activity(GO:0016853) |
0.2 | 1.1 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.2 | 1.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 2.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 3.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.4 | GO:0004620 | phospholipase activity(GO:0004620) |
0.2 | 1.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 7.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 37.7 | GO:0004672 | protein kinase activity(GO:0004672) |
0.2 | 4.5 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.2 | 1.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 6.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 1.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 26.5 | GO:0001882 | nucleoside binding(GO:0001882) |
0.2 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 1.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 1.0 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.2 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 1.6 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 2.0 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.2 | 6.4 | GO:0072509 | divalent inorganic cation transmembrane transporter activity(GO:0072509) |
0.2 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 2.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.2 | 1.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 3.6 | GO:0015297 | antiporter activity(GO:0015297) |
0.2 | 5.3 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.2 | 1.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 2.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.2 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 2.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.8 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.2 | 0.2 | GO:0005113 | patched binding(GO:0005113) smoothened binding(GO:0005119) |
0.2 | 7.5 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.2 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 8.0 | GO:0016874 | ligase activity(GO:0016874) |
0.2 | 0.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 1.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 2.2 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 0.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 0.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 2.8 | GO:0060090 | binding, bridging(GO:0060090) |
0.2 | 0.2 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.2 | 1.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.2 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.5 | GO:0020037 | heme binding(GO:0020037) |
0.2 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 2.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.2 | 1.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.2 | 1.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.2 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 3.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 3.1 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 32.8 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 8.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 6.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 1.0 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.1 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.1 | 1.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 3.8 | GO:0016757 | transferase activity, transferring glycosyl groups(GO:0016757) |
0.1 | 1.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 2.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 1.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 6.4 | GO:0015293 | symporter activity(GO:0015293) |
0.1 | 0.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 2.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.0 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 0.3 | GO:0042578 | phosphoric ester hydrolase activity(GO:0042578) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 3.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.7 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.1 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 1.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.8 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.1 | 0.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.2 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.8 | GO:0018447 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 45.6 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.2 | GO:0022832 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
0.1 | 0.7 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 3.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 0.6 | GO:0016829 | lyase activity(GO:0016829) |
0.1 | 0.2 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 43.9 | GO:0046872 | metal ion binding(GO:0046872) |
0.1 | 0.4 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.7 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 1.1 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.1 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.1 | 0.3 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.1 | 0.1 | GO:0030250 | cyclase regulator activity(GO:0010851) cyclase activator activity(GO:0010853) guanylate cyclase regulator activity(GO:0030249) guanylate cyclase activator activity(GO:0030250) |
0.1 | 5.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 2.5 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.0 | 0.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 9.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 1.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 76.8 | GO:0005515 | protein binding(GO:0005515) |
0.0 | 0.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.0 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 12.3 | GO:0004871 | signal transducer activity(GO:0004871) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 46.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
2.5 | 37.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
2.3 | 67.4 | PID REELIN PATHWAY | Reelin signaling pathway |
2.2 | 31.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.2 | 4.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
2.1 | 36.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
2.0 | 6.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
2.0 | 15.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
1.9 | 54.7 | PID RAS PATHWAY | Regulation of Ras family activation |
1.8 | 7.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.8 | 59.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.8 | 28.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.7 | 10.4 | PID IGF1 PATHWAY | IGF1 pathway |
1.7 | 10.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.7 | 67.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.7 | 26.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.7 | 28.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.6 | 28.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.6 | 24.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.6 | 3.2 | ST ADRENERGIC | Adrenergic Pathway |
1.6 | 20.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.5 | 49.5 | PID LKB1 PATHWAY | LKB1 signaling events |
1.5 | 17.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.5 | 20.7 | PID INSULIN PATHWAY | Insulin Pathway |
1.5 | 21.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.4 | 34.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.4 | 15.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.4 | 33.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.4 | 12.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.3 | 40.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
1.3 | 38.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.3 | 8.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.2 | 19.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.2 | 8.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.2 | 18.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.2 | 10.5 | PID ARF6 PATHWAY | Arf6 signaling events |
1.1 | 22.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.1 | 41.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
1.1 | 18.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.1 | 38.4 | PID NOTCH PATHWAY | Notch signaling pathway |
1.1 | 10.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.1 | 3.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.1 | 6.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.1 | 16.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.1 | 6.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.1 | 3.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.1 | 12.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.1 | 7.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.1 | 36.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.0 | 167.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.0 | 13.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.0 | 9.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.0 | 7.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.0 | 2.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.0 | 27.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.0 | 10.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.0 | 2.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.0 | 2.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.0 | 5.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.0 | 128.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.0 | 8.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.0 | 1.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.9 | 2.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.9 | 29.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.9 | 2.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.9 | 7.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.9 | 10.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.8 | 5.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.8 | 8.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 0.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.8 | 12.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.8 | 4.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.8 | 6.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.8 | 5.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.8 | 7.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.8 | 6.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.8 | 3.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.8 | 13.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.8 | 18.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.8 | 26.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.8 | 16.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.8 | 12.8 | PID FGF PATHWAY | FGF signaling pathway |
0.8 | 15.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.7 | 3.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.7 | 8.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.7 | 9.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.7 | 2.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.7 | 3.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.7 | 10.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.7 | 8.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.7 | 6.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.7 | 5.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.7 | 23.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.7 | 10.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 29.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.7 | 129.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.7 | 8.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.7 | 2.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.7 | 5.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 12.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 17.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.6 | 6.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.6 | 7.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.6 | 1.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.6 | 3.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.6 | 4.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 2.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.6 | 4.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.5 | 9.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.5 | 15.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.5 | 4.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 6.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.5 | 3.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.5 | 1.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 3.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 2.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.5 | 2.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 2.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.5 | 103.6 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.5 | 11.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 3.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 7.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.4 | 8.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 4.4 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.4 | 1.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 5.2 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 11.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 1.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.4 | 2.9 | PID MYC PATHWAY | C-MYC pathway |
0.4 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 2.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.3 | 7.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 2.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.3 | 3.4 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 1.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 8.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 0.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 3.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 2.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 2.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 2.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 4.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 4.1 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 1.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 1.1 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 24.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
3.9 | 34.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
3.7 | 3.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
3.6 | 39.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
3.5 | 59.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.5 | 38.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.4 | 146.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
3.2 | 32.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
3.2 | 38.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
3.1 | 43.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
3.1 | 43.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.0 | 48.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
3.0 | 35.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
2.8 | 11.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.8 | 30.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
2.6 | 26.2 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
2.5 | 63.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
2.5 | 5.0 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
2.5 | 56.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
2.4 | 14.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
2.3 | 4.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
2.3 | 6.9 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
2.3 | 32.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.3 | 74.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
2.2 | 6.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
2.2 | 6.7 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
2.2 | 41.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
2.1 | 40.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
2.1 | 40.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
2.0 | 20.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.0 | 16.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.9 | 13.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.9 | 23.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.9 | 15.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.9 | 9.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.8 | 11.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.8 | 7.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.8 | 34.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.8 | 19.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.8 | 14.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.8 | 3.5 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
1.7 | 21.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.7 | 11.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.6 | 13.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.6 | 45.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.6 | 30.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.6 | 56.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.6 | 36.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.6 | 3.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
1.6 | 18.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.5 | 6.2 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
1.5 | 33.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.5 | 4.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.5 | 21.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.5 | 12.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.5 | 14.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.5 | 14.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.4 | 11.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
1.4 | 8.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.4 | 17.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.4 | 4.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
1.4 | 9.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.4 | 31.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
1.3 | 16.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.3 | 6.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
1.3 | 10.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.3 | 81.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.3 | 7.7 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
1.3 | 14.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.2 | 18.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.2 | 2.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.2 | 21.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.2 | 23.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.2 | 14.8 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
1.2 | 4.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.2 | 13.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.2 | 8.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.1 | 13.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.1 | 12.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.1 | 18.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.1 | 3.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
1.1 | 22.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.1 | 7.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.1 | 10.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.1 | 10.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.1 | 21.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.1 | 4.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.1 | 16.9 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
1.1 | 13.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.1 | 16.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.0 | 3.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.0 | 31.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
1.0 | 1.0 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
1.0 | 19.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.0 | 12.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
1.0 | 11.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.0 | 7.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
1.0 | 10.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.0 | 47.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.0 | 29.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.9 | 5.6 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.9 | 61.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.9 | 0.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.9 | 1.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.9 | 56.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.9 | 7.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.9 | 9.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.9 | 10.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.9 | 2.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.9 | 9.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.9 | 4.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.9 | 36.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.9 | 10.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.9 | 1.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.9 | 15.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.9 | 8.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.9 | 32.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.8 | 3.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.8 | 0.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.8 | 11.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.8 | 17.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.8 | 1.6 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.8 | 3.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.8 | 3.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.8 | 19.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.8 | 0.8 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.8 | 10.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.8 | 14.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.8 | 3.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.8 | 6.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.7 | 1.5 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.7 | 35.6 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.7 | 5.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.7 | 8.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.7 | 2.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.7 | 10.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.7 | 5.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.7 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.7 | 20.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.7 | 7.9 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.7 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.7 | 4.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.7 | 0.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.7 | 13.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.7 | 9.1 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.7 | 6.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.7 | 9.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.7 | 10.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.7 | 24.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.7 | 6.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.7 | 2.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.7 | 1.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.7 | 15.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.7 | 50.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.6 | 10.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 5.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.6 | 8.2 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.6 | 2.5 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.6 | 15.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.6 | 43.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.6 | 8.5 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.6 | 4.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.6 | 4.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.6 | 4.7 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.6 | 8.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.6 | 8.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.6 | 8.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.6 | 4.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.6 | 18.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 11.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.5 | 64.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.5 | 3.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 5.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 11.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.5 | 10.4 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.5 | 0.5 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.5 | 10.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.5 | 4.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.5 | 3.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.5 | 56.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.5 | 5.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.5 | 6.3 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |
0.5 | 11.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.5 | 8.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 1.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.5 | 5.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.5 | 1.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.5 | 6.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 19.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.5 | 17.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.5 | 5.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.4 | 7.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 0.9 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.4 | 3.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.4 | 4.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 3.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 3.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 4.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.4 | 4.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 6.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 0.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.4 | 2.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 3.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 6.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.4 | 5.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 2.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.4 | 3.6 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.4 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 2.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 5.9 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.4 | 1.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 2.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.4 | 7.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 3.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 4.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.4 | 0.4 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.4 | 3.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 2.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 19.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 2.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 6.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 6.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 1.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 10.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 1.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.3 | 4.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 0.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.3 | 5.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 5.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 0.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.3 | 4.9 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.3 | 1.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 2.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 1.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 4.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 5.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.3 | 0.6 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 2.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 2.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 1.4 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.3 | 5.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 0.8 | REACTOME SIGNALING BY GPCR | Genes involved in Signaling by GPCR |
0.2 | 5.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 6.7 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 1.2 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.2 | 3.1 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.2 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 1.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 2.2 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.2 | 2.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 11.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 2.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 0.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 1.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 1.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 2.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 0.8 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 0.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.8 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 1.7 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 5.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 3.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 2.5 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.1 | 2.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 2.6 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.1 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 3.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.2 | REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | Genes involved in SLC-mediated transmembrane transport |
0.0 | 0.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |